<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <atom:link rel="self" type="application/rss+xml" href="https://escholarship.org/uc/ucsdsom_obgyn_oapdeposits/rss"/>
    <ttl>720</ttl>
    <title>Recent ucsdsom_obgyn_oapdeposits items</title>
    <link>https://escholarship.org/uc/ucsdsom_obgyn_oapdeposits/rss</link>
    <description>Recent eScholarship items from Department of OB/GYN &amp; Reproductive Sciences - Open Access Policy Deposits</description>
    <pubDate>Fri, 25 Sep 2026 20:44:38 +0000</pubDate>
    <item>
      <title>Immunoaffinity‐Based Protocol to Enrich Nervous System Cell‐, Lung Alveolar Cell‐, and Hepatocyte‐Derived Extracellular Vesicles From Human Plasma</title>
      <link>https://escholarship.org/uc/item/79p6j28s</link>
      <description>By preserving molecular information inherited from the source cell, extracellular vesicles (EVs) can serve as biomarkers for tissue health or disease, paving the way for liquid biopsy applications. The enrichment of tissue-specific EVs (TS-EVs) from human biofluids can be challenging due to technical and methodological limitations. Here, we use single and sequential immunoaffinity capture workflows to enrich antigen-specific EVs circulating in human blood. We demonstrate the specificity, efficiency, and consistency of our approach for enriching blood plasma EV subpopulations from the nervous system, alveolar cells and hepatocytes. The enriched subpopulations are characterized by canonical EV features and markers, as well as co-localization of tissue-specific and general markers on the surface. We provide a validated workflow to derive multiple EV subpopulations from circulation, leveraging their promise as informative biomarkers of tissue status and enabling liquid biopsy and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/79p6j28s</guid>
      <pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Pierri, Biancamaria</name>
      </author>
      <author>
        <name>Jackson, Gabriela L</name>
      </author>
      <author>
        <name>Gololobova, Olesia</name>
      </author>
      <author>
        <name>Wang, Fang</name>
      </author>
      <author>
        <name>Eitan, Erez</name>
      </author>
      <author>
        <name>Volpert, Olga</name>
      </author>
      <author>
        <name>Kalia, Vrinda</name>
      </author>
      <author>
        <name>Reyes‐Soffer, Gissette</name>
      </author>
      <author>
        <name>Laurent, Louise C</name>
        <uri>https://orcid.org/0000-0002-2095-7534</uri>
      </author>
      <author>
        <name>Witwer, Kenneth W</name>
      </author>
      <author>
        <name>Baccarelli, Andrea A</name>
      </author>
      <author>
        <name>Wu, Haotian</name>
      </author>
    </item>
    <item>
      <title>Postpartum Hemorrhagic Morbidities with Livebirth versus Stillbirth</title>
      <link>https://escholarship.org/uc/item/7615m7s2</link>
      <description>Objective: ACOG publications on stillbirth or postpartum hemorrhage (PPH) do not consider stillbirth as a risk factor for postpartum hemorrhagic morbidity. This study aimed to ascertain the likelihood of composite maternal hemorrhagic outcome (CMHO) among individuals who delivered vaginally with livebirth versus a stillbirth.
Study Design: This was a retrospective cohort study of all parturients greater than 20 weeks gestation who delivered vaginally at a single level IV site within 24 months. Demographic differences and baseline PPH risks were analyzed. CMHO included any of the following: estimated blood loss ≥1,000 mL, use of uterotonics (beyond prophylactic oxytocin), Bakri balloon, surgical management of PPH, blood transfusion, hysterectomy, venous thromboembolism (VTE), admission to the intensive care unit (ICU), or maternal death. Statistical analysis included chi-squared, Kruskal-Wallis, and Poisson regression with robust error variance for risk ratios, adjusting for gestational...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7615m7s2</guid>
      <pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Zullo, Fabrizio</name>
      </author>
      <author>
        <name>Wiley, Rachel L</name>
        <uri>https://orcid.org/0000-0003-2158-4482</uri>
      </author>
      <author>
        <name>Ghose, Ipsita</name>
      </author>
      <author>
        <name>Rizzo, Giuseppe</name>
      </author>
      <author>
        <name>Giancotti, Antonella</name>
      </author>
      <author>
        <name>Mendez-Figueroa, Hector</name>
      </author>
      <author>
        <name>Di Mascio, Daniele</name>
      </author>
      <author>
        <name>Chauhan, Suneet P</name>
      </author>
    </item>
    <item>
      <title>Delivery outcomes associated with resolved first‐trimester low placentation</title>
      <link>https://escholarship.org/uc/item/6vj2c47f</link>
      <description>Abstract  Introduction The majority of low placentation identified on first‐trimester transabdominal ultrasound resolves; however, whether this resolution is associated with adverse outcome remains poorly understood. This investigation aimed to determine whether patients with resolved first‐trimester low placentation had different delivery outcomes compared to patients who never had low placentation.   Methods This is a retrospective cohort study of singleton pregnancies with low placentation, defined as low‐lying placenta or placenta covering the internal os, on first‐trimester transabdominal ultrasound between 12+0&amp;nbsp;weeks and 13+6&amp;nbsp;weeks, delivering at a single tertiary care center from January to December 2022. We compared outcomes stratified by first‐trimester low placentation that resolved by the second trimester, or those without low placentation at any point. The primary outcome was quantitative blood loss at delivery by volumetric measurement. Secondary outcomes...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6vj2c47f</guid>
      <pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Feiner, Rachel</name>
      </author>
      <author>
        <name>Wiley, Rachel</name>
        <uri>https://orcid.org/0000-0003-2158-4482</uri>
      </author>
      <author>
        <name>Lamale‐Smith, Leah</name>
      </author>
      <author>
        <name>Teal, E Nicole</name>
      </author>
      <author>
        <name>Sarker, Minhazur</name>
      </author>
    </item>
    <item>
      <title>The association of maternal body mass index and cesarean delivery after preterm induction of labor</title>
      <link>https://escholarship.org/uc/item/69v5z234</link>
      <description>The association of maternal body mass index and cesarean delivery after preterm induction of labor</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/69v5z234</guid>
      <pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Sarker, Minhazur R</name>
      </author>
      <author>
        <name>Wiley, Rachel</name>
        <uri>https://orcid.org/0000-0003-2158-4482</uri>
      </author>
      <author>
        <name>Lacoursiere, Daphne Yvette</name>
      </author>
      <author>
        <name>Noonan, Grace</name>
      </author>
      <author>
        <name>Rogerson, Daniella</name>
      </author>
      <author>
        <name>Wen, Timothy</name>
      </author>
      <author>
        <name>Gyamfi-Bannerman, Cynthia</name>
      </author>
      <author>
        <name>Emeruwa, Ukachi N</name>
      </author>
    </item>
    <item>
      <title>Fetal Heart Rate Tracings and Adverse Outcomes among Term Small versus Appropriate for Gestational Age</title>
      <link>https://escholarship.org/uc/item/5q82m2br</link>
      <description>Objective: This study aimed to compare the patterns of fetal heart rate tracings (FHRTs), and outcomes among individuals with small (birth weight [BW] &amp;lt;10% for gestational age [GA]; SGA) versus appropriate (BW at 10-89% for GA; AGA) newborns at term (≥37.0 weeks).
Study Design: Our retrospective cohort study included consecutive deliveries over 15 months at a level IV center. FHRTs were reviewed by obstetricians blinded to maternal and neonatal outcomes. The inclusion criteria were non-anomalous singletons, cataloged as SGA or AGA birth weight using Alexander et al's nomogram. In 20-minute segments, the last 120 minutes of tracing were characterized. Rates of cesarean delivery (CD) and composite neonatal adverse outcomes (CNAOs) were compared.
Results: Of 5,160 deliveries, 3,029 (58.7%) met the inclusion criteria, and among them, 422 (13.9%) were SGA and 2,607 (86.1%) AGA. There were no differences in FHRT baseline, variability, or accelerations. Compared to AGA, SGA was more...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5q82m2br</guid>
      <pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Patel, Shareen</name>
      </author>
      <author>
        <name>Cagino, Kristen A</name>
      </author>
      <author>
        <name>Roberts, Aaron W</name>
      </author>
      <author>
        <name>Wiley, Rachel L</name>
        <uri>https://orcid.org/0000-0003-2158-4482</uri>
      </author>
      <author>
        <name>Cortes, Christina</name>
      </author>
      <author>
        <name>Zullo, Fabrizio</name>
      </author>
      <author>
        <name>Mendez-Figueroa, Hector</name>
      </author>
      <author>
        <name>Chauhan, Suneet P</name>
      </author>
    </item>
    <item>
      <title>Tachycardia in Pregnancy</title>
      <link>https://escholarship.org/uc/item/3cv3g99q</link>
      <description>Tachycardia in Pregnancy</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3cv3g99q</guid>
      <pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Wiley, Rachel L</name>
        <uri>https://orcid.org/0000-0003-2158-4482</uri>
      </author>
      <author>
        <name>Herrick, Nicky L</name>
      </author>
      <author>
        <name>Tarsa, Maryam</name>
      </author>
    </item>
    <item>
      <title>Association of Fetal Heart Rate Tracing with Adverse Neonatal Outcomes at 32 0/7 to 36 6/7 Weeks</title>
      <link>https://escholarship.org/uc/item/14g688nt</link>
      <description>Objective: The objective of this study is to determine if patterns of fetal heart rate tracings (FHRT) were associated with an increased rate of composite adverse neonatal outcomes (CANO) among preterm deliveries at 32&lt;sup&gt;0/7&lt;/sup&gt; to 36&lt;sup&gt;6/7&lt;/sup&gt; weeks.
Study Design: This was a retrospective review of intrapartum FHRT between 20 and 120 minutes before birth, among nonanomalous singletons delivered at 32&lt;sup&gt;0/7&lt;/sup&gt; to 36&lt;sup&gt;6/7&lt;/sup&gt; weeks. The study was conducted at a Level IV maternal center during a consecutive 15-month period. Obstetricians reviewing FHRT were blinded to the maternal characteristics, intrapartum course, and neonatal outcomes. FHRT patterns were categorized based on time spent in the final 2 hours before delivery (&amp;lt;50 vs. ≥50%). The primary outcome was the CANO, which included any of the following: 5-minute Apgar &amp;lt; 7, mechanical ventilation &amp;gt; 6 hours, umbilical artery pH &amp;lt; 7.00, bronchopulmonary dysplasia, interventricular hemorrhage, necrotizing...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/14g688nt</guid>
      <pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Cortes, Christina N</name>
      </author>
      <author>
        <name>Cagino, Kristen A</name>
      </author>
      <author>
        <name>Roberts, Aaron W</name>
      </author>
      <author>
        <name>Wiley, Rachel L</name>
        <uri>https://orcid.org/0000-0003-2158-4482</uri>
      </author>
      <author>
        <name>Patel, Shareen</name>
      </author>
      <author>
        <name>Zullo, Fabrizio</name>
      </author>
      <author>
        <name>Mendez-Figueroa, Hector</name>
      </author>
      <author>
        <name>Chauhan, Suneet P</name>
      </author>
    </item>
    <item>
      <title>Effect of updated best practices on ultrasound-guided peripheral IV dwell time in children</title>
      <link>https://escholarship.org/uc/item/0kp1f814</link>
      <description>IMPORTANCE: Placement of intravenous access is challenging in pediatric patients. Complications and replacement of IV access is a common occurrence in pediatric patients.
OBJECTIVE: This project evaluated a new training program for placement of pediatric USGIV lines.
DESIGN: Quality improvement: pre-post cohort.
SETTING: A tertiary pediatric hospital in the southwest United States.
PARTICIPANTS: The pre-intervention cohort included 400 IV lines identified through retrospective chart review. A subset of 68 lines placed in the three months prior to the intervention were specific to the nurses undergoing training. The post-intervention cohort consisted of 359 lines obtained via convenience sampling. Lines were excluded if documentation lacked insertion/removal dates or reasons for removal.
METHODS: The educational intervention was based on best practices, including appropriate catheter-to-vessel diameter ratios and optimal catheter length within the vessel. Training was delivered...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0kp1f814</guid>
      <pubDate>Tue, 18 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Bauernsmith, Ian</name>
      </author>
      <author>
        <name>Davidson, Judy</name>
      </author>
      <author>
        <name>Burnett, Lindsey</name>
      </author>
    </item>
    <item>
      <title>Multiple recurrences of postmenopausal endometriosis associated with estrogen pellet therapy: clinical implications for hormone therapy and surgical management.</title>
      <link>https://escholarship.org/uc/item/9ns6m6f0</link>
      <description>OBJECTIVES: To challenge the perception that endometriosis uniformly regresses after menopause by presenting the case of repeated, pathology-confirmed symptomatic recurrences spanning two decades after menopause, and to emphasize key considerations for hormone therapy use and surgical management in postmenopausal endometriosis.
METHODS: We report the case of a 70-year-old postmenopausal patient with prior hysterectomy, bilateral salpingo-oophorectomy, appendectomy, and pathology-confirmed endometriosis who presented with pelvic pain while receiving subcutaneous estrogen pellet therapy. Preoperative imaging was suggestive of recurrent endometriosis. The patient underwent laparoscopic excision for diagnostic and therapeutic purposes, with final pathology confirming recurrent disease. Written informed consent was obtained for publication of this case report and use of de-identified clinical images. A focused narrative literature review was performed to contextualize this case within...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9ns6m6f0</guid>
      <pubDate>Mon, 10 Aug 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Wu, Esther</name>
      </author>
      <author>
        <name>Nassar, Daniel T</name>
        <uri>https://orcid.org/0000-0003-2129-8945</uri>
      </author>
      <author>
        <name>Ginn, Daniel N</name>
      </author>
      <author>
        <name>Romeroso, Brianne D</name>
      </author>
    </item>
    <item>
      <title>Haploinsufficiency of Sox2 causes fewer GnRH neurons and delayed puberty in mice</title>
      <link>https://escholarship.org/uc/item/49v5295n</link>
      <description>Mutations in the SOX2 gene have been previously linked to a syndromic form of isolated hypogonadotropic hypogonadism, with additional ocular and neurodevelopmental phenotypes. Recently, we reported a functional role for SOX2 in hypothalamic kisspeptin-expressing neurons and established a mechanistic relationship between SOX2 heterozygous variants and isolated hypogonadotropic hypogonadism. To further test the role of Sox2 in the hypothalamic-pituitary-gonadal axis, we generated mice with a whole-body heterozygous knockout of Sox2 (Sox2WT/KO). We found that heterozygous loss of Sox2 significantly delayed pubertal onset in both male and female Sox2WT/KO mice compared to wild-ype (WT) controls. In females, fertility was also compromised, with fewer estrous cycles and a significant delay in time to first litter of Sox2WT/KO dams compared to WT controls. Circulating levels of gonadotropins were normal in both male and female Sox2WT/KO mice, suggesting a functional pituitary. Finally,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/49v5295n</guid>
      <pubDate>Thu, 4 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Cassin, Jessica</name>
      </author>
      <author>
        <name>Dunn, Geneva A</name>
      </author>
      <author>
        <name>Nguyen, Ryan D</name>
      </author>
      <author>
        <name>Chen, Vivian</name>
      </author>
      <author>
        <name>Duong, Annie X</name>
      </author>
      <author>
        <name>Esparza, Lourdes A</name>
      </author>
      <author>
        <name>Tripuraneni, Isha</name>
      </author>
      <author>
        <name>Kauffman, Alexander S</name>
        <uri>https://orcid.org/0000-0001-8631-6097</uri>
      </author>
      <author>
        <name>Tonsfeldt, Karen J</name>
      </author>
      <author>
        <name>Mellon, Pamela L</name>
        <uri>https://orcid.org/0000-0002-8856-0410</uri>
      </author>
    </item>
    <item>
      <title>Surging towards a better understanding of ovulation.</title>
      <link>https://escholarship.org/uc/item/1hx0x35d</link>
      <description>The ability to record the real-time activity of specialized neurons in the brains of female mice is providing new insights into the hormonal control of ovulation.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1hx0x35d</guid>
      <pubDate>Thu, 4 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Rose, Lillian</name>
      </author>
      <author>
        <name>Kauffman, Alexander S</name>
        <uri>https://orcid.org/0000-0001-8631-6097</uri>
      </author>
    </item>
    <item>
      <title>FAK inhibition in ovarian cancer releases omega-3 fatty acids to program CXCL13-producing anti-tumor resident peritoneal macrophages</title>
      <link>https://escholarship.org/uc/item/43j3k2w6</link>
      <description>High-grade serous ovarian cancer (HGSOC) is a lethal malignancy characterized by therapy resistance. Focal adhesion kinase (FAK) is highly expressed in HGSOC, yet its impact on tumor-immune communication remains incompletely defined. Using three syngeneic ovarian cancer models, we show that FAK inhibition (FAKi) increased macrophage CXCL13 expression and promoted peritoneal B cell infiltration. Combining FAKi with low-dose pegylated doxorubicin and anti-T cell immunoreceptor with Ig and ITIM domains (TIGIT) checkpoint blockade suppressed orthotopic ovarian tumor growth, extended survival, and induced tertiary lymphoid structures. Macrophage lineage factor GATA6 inactivation reduced CXCL13 expression, enhanced FAK-knockout tumor growth, and limited ascites B cell accumulation. Mechanistically, FAKi-treated or FAK-deficient tumor cells release exosomes enriched in omega-3 fatty acids that stimulated macrophage CXCL13 production. Exposure of macrophages to tumor-derived omega-3 lipids...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/43j3k2w6</guid>
      <pubDate>Fri, 15 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Chen, Xiao Lei</name>
        <uri>https://orcid.org/0000-0001-7998-9963</uri>
      </author>
      <author>
        <name>Tharp, Kevin M</name>
      </author>
      <author>
        <name>Ojalill, Marjaana</name>
      </author>
      <author>
        <name>Ozmadenci, Duygu</name>
      </author>
      <author>
        <name>Boyer, Antonia</name>
      </author>
      <author>
        <name>Haanen, Terrance J</name>
      </author>
      <author>
        <name>Lawson, Christine</name>
      </author>
      <author>
        <name>Lee, Hyojae J</name>
      </author>
      <author>
        <name>Xia, Marvin</name>
      </author>
      <author>
        <name>Tahon, Elise</name>
      </author>
      <author>
        <name>Zhang, Yichi</name>
      </author>
      <author>
        <name>Minor, Cray</name>
      </author>
      <author>
        <name>Khan, Safir Ullah</name>
      </author>
      <author>
        <name>Anderson, Colin C</name>
      </author>
      <author>
        <name>Nemkov, Travis</name>
      </author>
      <author>
        <name>Rose, Michael</name>
      </author>
      <author>
        <name>Estrada, Monica V</name>
      </author>
      <author>
        <name>Molinolo, Alfredo A</name>
      </author>
      <author>
        <name>Warren, Elias</name>
      </author>
      <author>
        <name>Penalosa, Patrick</name>
      </author>
      <author>
        <name>Eskander, Ramez N</name>
      </author>
      <author>
        <name>McHale, Michael T</name>
      </author>
      <author>
        <name>Wang, Shizhen E</name>
      </author>
      <author>
        <name>Connolly, Denise C</name>
      </author>
      <author>
        <name>Fisch, Kathleen M</name>
        <uri>https://orcid.org/0000-0002-0117-7444</uri>
      </author>
      <author>
        <name>Stupack, Dwayne G</name>
      </author>
      <author>
        <name>Schlaepfer, David D</name>
        <uri>https://orcid.org/0000-0003-4814-9210</uri>
      </author>
    </item>
    <item>
      <title>Liposomal Doxorubicin, but Not Platinum-Taxane, Supports MHC-II Expression and Immune Maturation in the Ovarian Tumor Microenvironment</title>
      <link>https://escholarship.org/uc/item/263804k5</link>
      <description>BACKGROUND: Ovarian cancer is an immunologically cold tumor that is treated with surgery and a chemotherapy regimen of platinum agents with taxanes. Paradoxically, elevated levels of several immune markers are effective at predicting prognosis for patients with ovarian cancer, though it is not clear how chemotherapy might influence this. Chemotherapy elicits immunogenic cell death, yet tumor-controlling doses of chemotherapy are also immunotoxic.
OBJECTIVES: To evaluate interactions of chemotherapy with the immune system, we studied the impact of chemotherapy in an aggressive mouse model of ovarian cancer developed within our lab.
METHODS: Using a single-cell transcriptomics sequencing approach, supported by flow cytometry, we evaluated the influence of a first-line therapy, cisplatin and docetaxel, and a second-line therapy, pegylated liposomal doxorubicin (PLD), on control of tumor growth and on tumor-associated immune populations of cells.
RESULTS: Both chemotherapy approaches...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/263804k5</guid>
      <pubDate>Fri, 15 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Lee, Hyojae</name>
      </author>
      <author>
        <name>Chen, Xiao-Lei</name>
        <uri>https://orcid.org/0000-0001-7998-9963</uri>
      </author>
      <author>
        <name>Ozmadenci, Duygu</name>
      </author>
      <author>
        <name>Tahon, Elise</name>
      </author>
      <author>
        <name>Haanan, Terrance J</name>
      </author>
      <author>
        <name>Hill, Breana</name>
      </author>
      <author>
        <name>Khan, Safir Ullah</name>
      </author>
      <author>
        <name>Boyer, Antonia</name>
        <uri>https://orcid.org/0009-0008-2716-8280</uri>
      </author>
      <author>
        <name>Schlaepfer, David D</name>
        <uri>https://orcid.org/0000-0003-4814-9210</uri>
      </author>
      <author>
        <name>Stupack, Dwayne</name>
      </author>
    </item>
    <item>
      <title>Kisspeptin made in the preoptic area is required for normal estradiol-induced LH surges and optimal fertility in females</title>
      <link>https://escholarship.org/uc/item/4wn1z5rf</link>
      <description>Ovulation is triggered by a surge in luteinizing hormone (LH) secretion from the pituitary. The LH surge is itself driven by a surge in GnRH release induced by estrogen positive feedback action in the hypothalamus. While ERα-expressing kisspeptin (Kiss1) neurons in the preoptic area (in mice, the rostral periventricular region of the third ventricle [RP3V]) are proposed to mediate this estrogen positive feedback event, the functional necessity of RP3V-derived kisspeptin for the LH surge has not been directly tested. Here we leveraged Cre/lox technology and the known high co-expression of tyrosine hydroxylase (TH) with Kiss1 in only the RP3V region to generate novel transgenic mice with selective knockout (KO) of the Kiss1 gene in just RP3V neurons (Kiss1RP3V KO mice). In situ hybridization confirmed a significant 70% reduction in cells expressing Kiss1 in the RP3V region, but not in the arcuate nucleus, along with no change in RP3V Th expression. Kiss1RP3V KO females exhibited...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4wn1z5rf</guid>
      <pubDate>Thu, 7 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Puffer, Marina S</name>
      </author>
      <author>
        <name>Yang, Jason</name>
      </author>
      <author>
        <name>Esparza, Lourdes A</name>
      </author>
      <author>
        <name>Rose, Lillian</name>
      </author>
      <author>
        <name>Duong, Viet</name>
      </author>
      <author>
        <name>Radovick, Sally</name>
      </author>
      <author>
        <name>Kauffman, Alexander S</name>
      </author>
    </item>
    <item>
      <title>Mode of delivery among pregnant people with obesity undergoing labor induction in the late preterm period</title>
      <link>https://escholarship.org/uc/item/6rg12534</link>
      <description>Introduction: Pregnant people with obesity are more likely than those without obesity to undergo induction of labor and to require unplanned cesarean delivery during induction at term. Whether they are more likely to undergo unplanned cesarean delivery during preterm induction of labor is unknown. This study examines the induction of labor success among people with obesity undergoing indicated late preterm induction of labor.
Methods: This is a secondary analysis of a multicenter, randomized trial of betamethasone versus placebo among pregnancies at risk for late preterm delivery, defined as delivery between 34 weeks and 0 days and 36 weeks and 6 days between 2010 and 2015. This study included pregnant people with live singleton nonanomalous gestations at high risk for late preterm delivery before 36 weeks and 6 days. This secondary analysis included all participants who underwent a medically indicated preterm induction of labor starting before 36 weeks and 5 days. We excluded...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6rg12534</guid>
      <pubDate>Tue, 14 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Rogerson, Daniella</name>
      </author>
      <author>
        <name>Sarker, Minhazur</name>
      </author>
      <author>
        <name>Sutton, Alice</name>
      </author>
      <author>
        <name>Teal, E Nicole</name>
      </author>
      <author>
        <name>Gyamfi‐Bannerman, Cynthia</name>
      </author>
    </item>
    <item>
      <title>Induction of Labor Is Not Associated with Decreased Rates of Breastfeeding in Late Preterm Pregnancies</title>
      <link>https://escholarship.org/uc/item/1ft4n52p</link>
      <description>Background Some studies suggest that induction of labor at term is associated with lower rates of breastfeeding than spontaneous labor. Objective Our objective was to evaluate whether late preterm medically indicated induction of labor is associated with decreased rates of breastfeeding and/or increased rates of breastfeeding complications at the time of discharge from the delivery hospitalization. Study Design This secondary analysis of a randomized trial of individuals at high risk for late preterm delivery, defined as delivery between 34+0 and 36+6 weeks, included non-anomalous, singleton pregnancies and excluded those with unlabored cesareans or preterm prelabor rupture of membranes. The parent study collected detailed data on breastfeeding and the presence of breastfeeding difficulties, defined as issues in milk production or infant feeding. Subjects with incomplete breastfeeding data were additionally excluded. Participants undergoing late preterm indicted inductions were...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1ft4n52p</guid>
      <pubDate>Tue, 14 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Sutton, Alice</name>
      </author>
      <author>
        <name>Rogerson, Daniella</name>
      </author>
      <author>
        <name>Thomson, Samantha</name>
      </author>
      <author>
        <name>Frugoni, Gina</name>
      </author>
      <author>
        <name>Gyamfi-Bannerman, Cynthia</name>
      </author>
    </item>
    <item>
      <title>Menstrual Dysfunction Is Associated With Elevated Liver Enzymes in Adolescent Females: A United States Population-Based Study</title>
      <link>https://escholarship.org/uc/item/8vk6k9c9</link>
      <description>Purpose Polycystic ovary syndrome and metabolic dysfunction–associated steatotic liver disease (MASLD) both emerge during adolescence; however, it remains unknown whether menstrual abnormalities and hyperandrogenism signals increased hepatic risk. Methods We analyzed 2011–2020 National Health and Nutrition Examination Survey data for 1,651 females aged 12–19 years in the United States who were at least 2 years postmenarche. Amenorrhea was defined as self-reported absence of menses in the past 12 months. Biochemical hyperandrogenism was defined as free androgen index ≥5. Elevated alanine aminotransferase (ALT; &amp;gt;22 U/L) was the primary hepatic outcome; suspected MASLD was defined as elevated ALT plus ≥1 cardiometabolic risk factor. Survey-weighted logistic regression models adjusted for age, race and ethnicity, and body mass index (BMI) percentile. Results Amenorrhea was reported by 2.8% of participants and was associated with higher odds of elevated ALT (adjusted odds ratio...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8vk6k9c9</guid>
      <pubDate>Tue, 3 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Noon, Sheila L</name>
      </author>
      <author>
        <name>Chun, Lauren F</name>
      </author>
      <author>
        <name>Mackay, Gillian</name>
      </author>
      <author>
        <name>Schwimmer, Jeffrey B</name>
      </author>
    </item>
    <item>
      <title>Workup and Management of Polycystic Ovary Syndrome</title>
      <link>https://escholarship.org/uc/item/01c4q3sd</link>
      <description>Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in females. It is a heterogeneous condition that frequently manifests in adolescence. Signs and symptoms include various combinations of hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. The etiology of PCOS is still largely unknown, although genetic and environmental factors, including insulin resistance and obesity, have been implicated. Diagnosis is based on the fulfillment of the 2003 Rotterdam criteria, which require two of three cardinal features – hyperandrogenism, oligomenorrhea, or amenorrhea – and polycystic ovaries on ultrasound. Careful history and physical examination are critical first steps in evaluation. Initial evaluation also involves documenting the presence of hyperandrogenism and ruling out other diagnoses. Ultrasound imaging should be considered as part of the initial evaluation and monitoring but is not necessary for all patients. Treatment remains largely empirical with an...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/01c4q3sd</guid>
      <pubDate>Tue, 3 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Regens, Alexandra</name>
      </author>
      <author>
        <name>Mackay, Gillian</name>
      </author>
      <author>
        <name>Maxwell, Jack</name>
      </author>
    </item>
    <item>
      <title>Genetic variants reshape the m6A epitranscriptome and drive transcriptomic reprogramming in colorectal cancer</title>
      <link>https://escholarship.org/uc/item/6kx696jf</link>
      <description>Genome-wide association studies (GWAS) have identified numerous single-nucleotide polymorphisms (SNPs) associated with various diseases, including cancer. However, the mechanisms by which these SNPs contribute to disease susceptibility remain largely unclear. While recent studies have explored the transcriptional impact of disease-associated SNPs, their role in post-transcriptional regulation has been less extensively investigated. In this study, we investigated whether cancer-associated SNPs influence gene expression by altering N6-methyladenosine (m6A) RNA methylation. We collected GWAS-identified SNPs across nine cancer types and integrated these with matched tumor and normal m6A RNA immunoprecipitation sequencing (m6A-seq) and RNA sequencing (RNA-seq) datasets. We first identified differentially methylated m6A sites and assessed whether cancer-associated SNPs were enriched within these regions. These analyses revealed that cancer-associated SNPs were significantly enriched...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6kx696jf</guid>
      <pubDate>Thu, 26 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Han, Seung Hun</name>
      </author>
      <author>
        <name>Jang, Seongmin</name>
      </author>
      <author>
        <name>Kim, Yeongwon</name>
      </author>
      <author>
        <name>Tan, Kun</name>
        <uri>https://orcid.org/0000-0002-8567-7795</uri>
      </author>
      <author>
        <name>Wilkinson, Miles F</name>
      </author>
      <author>
        <name>Jeong, Hyobin</name>
      </author>
      <author>
        <name>Choe, Junho</name>
      </author>
    </item>
    <item>
      <title>Malignant a-to-I RNA Editing By ADAR1 Drives T-Cell Acute Lymphoblastic Leukemia Relapse Via Attenuating dsRNA Sensing</title>
      <link>https://escholarship.org/uc/item/9pn9j344</link>
      <description>T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy that frequently occurs in children, adolescents, and young adults. Approximately 10-20% of T-ALL patients will experience relapse months or years following remission and will often become refractory to further treatments. The survival of relapsed/refractory patients is very poor, with an overall survival rate of less than a 25% overall survival rate. Relapsed patients often have enriched pools of leukemia initiating cells (LICs) with enhanced pro-survival and self-renewal capacity, suggesting a potential vulnerable population for effective targeted therapies with less toxicity. An emerging research topic in LIC biology is the identification of RNA modifying enzymes that are important for LIC self-renewal and survival. ADAR1 enzymes catalyze the transition of adenosine (A) to inosine (I) in precursor double-stranded RNA (dsRNA). Epitranscriptomic A-to-I RNA editing events are widespread in the...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9pn9j344</guid>
      <pubDate>Thu, 12 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Rivera, Maria D</name>
      </author>
      <author>
        <name>Pham, Jessica</name>
      </author>
      <author>
        <name>Isquith, Jane</name>
      </author>
      <author>
        <name>Zhang, Haoran</name>
      </author>
      <author>
        <name>Zhou, Jenny</name>
      </author>
      <author>
        <name>Sasik, Roman</name>
      </author>
      <author>
        <name>Mark, Adam</name>
      </author>
      <author>
        <name>Ma, Wenxue</name>
        <uri>https://orcid.org/0000-0001-9228-6162</uri>
      </author>
      <author>
        <name>Holm, Frida</name>
      </author>
      <author>
        <name>Fisch, Kathleen</name>
        <uri>https://orcid.org/0000-0002-0117-7444</uri>
      </author>
      <author>
        <name>Kuo, Dennis John</name>
      </author>
      <author>
        <name>Jamieson, Catriona</name>
      </author>
      <author>
        <name>Jiang, Qingfei</name>
      </author>
    </item>
    <item>
      <title>Barriers to specialty care among patients with vulvovaginal symptoms: findings from a retrospective cohort of vulvovaginal clinic patients</title>
      <link>https://escholarship.org/uc/item/72m5v993</link>
      <description>Barriers to specialty care among patients with vulvovaginal symptoms: findings from a retrospective cohort of vulvovaginal clinic patients</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/72m5v993</guid>
      <pubDate>Thu, 12 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Davis, Seetha H</name>
      </author>
      <author>
        <name>Martinez, Sarah</name>
      </author>
      <author>
        <name>Fulton, Tiffany Minors</name>
      </author>
      <author>
        <name>Farid, Huma</name>
      </author>
      <author>
        <name>McKinney, Sara</name>
      </author>
    </item>
    <item>
      <title>Joint, multifaceted genomic analysis enables diagnosis of diverse, ultra-rare monogenic presentations</title>
      <link>https://escholarship.org/uc/item/0s6684m8</link>
      <description>Genomics for rare disease diagnosis has advanced at a rapid pace due to our ability to perform in-depth analyses on individual patients with ultra-rare diseases. The increasing sizes of ultra-rare disease cohorts internationally newly enables cohort-wide analyses for new discoveries, but well-calibrated statistical genetics approaches for jointly analyzing these patients are still under development. The Undiagnosed Diseases Network (UDN) brings multiple clinical, research and experimental centers under the same umbrella across the United States to facilitate and scale case-based diagnostic analyses. Here, we present the first joint analysis of whole genome sequencing data of UDN patients across the network. We introduce new, well-calibrated statistical methods for prioritizing disease genes with de novo recurrence and compound heterozygosity. We also detect pathways enriched with candidate and known diagnostic genes. Our computational analysis, coupled with a systematic clinical...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0s6684m8</guid>
      <pubDate>Mon, 26 Jan 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Kobren, Shilpa Nadimpalli</name>
      </author>
      <author>
        <name>Moldovan, Mikhail A</name>
      </author>
      <author>
        <name>Reimers, Rebecca</name>
        <uri>https://orcid.org/0000-0001-8922-0015</uri>
      </author>
      <author>
        <name>Traviglia, Daniel</name>
      </author>
      <author>
        <name>Li, Xinyun</name>
      </author>
      <author>
        <name>Barnum, Danielle</name>
      </author>
      <author>
        <name>Veit, Alexander</name>
      </author>
      <author>
        <name>Corona, Rosario I</name>
      </author>
      <author>
        <name>Carvalho Neto, George de V</name>
      </author>
      <author>
        <name>Willett, Julian</name>
      </author>
      <author>
        <name>Berselli, Michele</name>
      </author>
      <author>
        <name>Ronchetti, William</name>
      </author>
      <author>
        <name>Nelson, Stanley F</name>
        <uri>https://orcid.org/0000-0002-2082-3114</uri>
      </author>
      <author>
        <name>Martinez-Agosto, Julian A</name>
      </author>
      <author>
        <name>Sherwood, Richard</name>
      </author>
      <author>
        <name>Krier, Joel</name>
      </author>
      <author>
        <name>Kohane, Isaac S</name>
      </author>
      <author>
        <name>Sunyaev, Shamil R</name>
      </author>
    </item>
    <item>
      <title>Integrating community perspectives to improve survey completion rates in public health research by refining controversial survey elements</title>
      <link>https://escholarship.org/uc/item/9cx4991t</link>
      <description>Background: Many factors can impact survey completion rates, including survey length, sensitivity of the topics addressed, and clarity of wording. This study used cognitive interviews (CIs), a methodological tool that can aid in developing and refining elements for multi-faceted assessments, and previous survey response patterns to refine, streamline, and increase response rates of RADx-UP Common Data Elements (CDEs) for survey/questionnaire use.
Methods: Ten previously enrolled CO-CREATE study participants were interviewed between May-June 2023. Interviewees identified CDEs that were "confusing, uncomfortable, and/or not applicable," along with their reasoning. Interview data were analyzed using a rapid qualitative analytic approach, resulting in a summary matrix categorized by language. For further contextualization, CDE response rates were calculated for the 9147 surveys administered during the CO-CREATE study (May 2021-March 2023) and compared against their survey position.
Results:...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9cx4991t</guid>
      <pubDate>Thu, 4 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Escoto, Arleth A</name>
      </author>
      <author>
        <name>Lomeli, Angel</name>
      </author>
      <author>
        <name>Burola, Maria Linda</name>
      </author>
      <author>
        <name>Reyes, Breanna</name>
      </author>
      <author>
        <name>Perez-Portillo, Ana</name>
      </author>
      <author>
        <name>Flores, Scarlet</name>
      </author>
      <author>
        <name>Kornher, Kayleigh</name>
      </author>
      <author>
        <name>Porras, Norma</name>
      </author>
      <author>
        <name>Cohen, Ariel</name>
      </author>
      <author>
        <name>Salgin, Linda</name>
      </author>
      <author>
        <name>Rabin, Borsika A</name>
      </author>
      <author>
        <name>Laurent, Louise C</name>
      </author>
      <author>
        <name>Seifert, Marva</name>
        <uri>https://orcid.org/0000-0002-7554-6396</uri>
      </author>
      <author>
        <name>Stadnick, Nicole A</name>
        <uri>https://orcid.org/0000-0001-6520-2920</uri>
      </author>
    </item>
    <item>
      <title>Sources of successful participant engagement in a public health research study: A focus on a Latino community</title>
      <link>https://escholarship.org/uc/item/23j89239</link>
      <description>BACKGROUND: Latino populations remain vastly underrepresented in clinical and translational research. This study aims to characterize the most common sources of successful participant engagement within our sample.
METHODS: Between February 2022 and March 2023, research staff systematically recorded how participants learned about an ongoing study (which we term source of successful participant engagement) designed to co-create and implement a COVID-19 testing program in a U.S./Mexico border community. Demographic characteristics were correlated with each source of participant engagement at the univariate level using a chi-squared test and, if significant, were included in a multinomial logistic regression model to determine the association between participant characteristics and source of participant engagement.
RESULTS: A total of 2836 individuals responded to questions regarding source of participant engagement; the most common responses were: Word of Mouth (32%), Clinic/Provider...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/23j89239</guid>
      <pubDate>Thu, 4 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Lomeli, Angel</name>
      </author>
      <author>
        <name>Escoto, Arleth A</name>
      </author>
      <author>
        <name>Reyes, Breanna</name>
      </author>
      <author>
        <name>Kornher, Kayleigh</name>
      </author>
      <author>
        <name>Beltran-Murillo, Keira</name>
      </author>
      <author>
        <name>Nuñez, Kathia</name>
      </author>
      <author>
        <name>Cohen, Ariel</name>
      </author>
      <author>
        <name>Burola, Maria Linda</name>
      </author>
      <author>
        <name>Villegas, Isabel</name>
      </author>
      <author>
        <name>Flores, Scarlet</name>
      </author>
      <author>
        <name>Perez-Portillo, Ana</name>
      </author>
      <author>
        <name>Porras, Norma</name>
      </author>
      <author>
        <name>Torres, Melody</name>
      </author>
      <author>
        <name>Salgin, Linda</name>
      </author>
      <author>
        <name>Cain, Kelli L</name>
      </author>
      <author>
        <name>Stadnick, Nicole A</name>
        <uri>https://orcid.org/0000-0001-6520-2920</uri>
      </author>
      <author>
        <name>Laurent, Louise C</name>
        <uri>https://orcid.org/0000-0002-2095-7534</uri>
      </author>
      <author>
        <name>Rabin, Borsika A</name>
      </author>
      <author>
        <name>Seifert, Marva</name>
        <uri>https://orcid.org/0000-0002-7554-6396</uri>
      </author>
    </item>
    <item>
      <title>Exploratory analysis of placenta accreta spectrum content on TikTok using #placentaaccreta, #accreta, and #placentaprevia</title>
      <link>https://escholarship.org/uc/item/5b39w4fm</link>
      <description>Exploratory analysis of placenta accreta spectrum content on TikTok using #placentaaccreta, #accreta, and #placentaprevia</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5b39w4fm</guid>
      <pubDate>Fri, 7 Nov 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Sarker, Minhazur</name>
      </author>
      <author>
        <name>Wiley, Rachel</name>
      </author>
      <author>
        <name>Harvey, Scott</name>
      </author>
      <author>
        <name>Nhan-Chang, Chia-Ling</name>
      </author>
      <author>
        <name>Ballas, Jerasimos</name>
      </author>
    </item>
    <item>
      <title>Postpartum Hemorrhage</title>
      <link>https://escholarship.org/uc/item/05q5k0r6</link>
      <description>This JAMA Insights discusses risk factors for, assessment, and management of postpartum hemorrhage.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/05q5k0r6</guid>
      <pubDate>Fri, 7 Nov 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Harvey, Scott A</name>
      </author>
    </item>
    <item>
      <title>Predictive Capacity of First-Trimester Diagnosis of Placenta Previa</title>
      <link>https://escholarship.org/uc/item/16q574bw</link>
      <description>First-trimester transabdominal ultrasound (TAUS) is sometimes used to diagnose placenta previa and counsel patients accordingly. We aimed to determine the predictive capacity of a first-trimester transabdominal ultrasonographic placenta previa diagnosis for persistence to the second trimester.Retrospective cohort study of patients with singleton pregnancies and first-trimester transabdominal ultrasonographic placenta previa diagnoses from January to December 2022. The primary outcome was the predictive capacity of a first-trimester TAUS diagnosis of placenta previa for placenta previa persistence into the second trimester. Secondary outcomes included the predictive capacity of a first-trimester TAUS for placenta previa persistence to delivery and risk factors associated with placenta previa persistence. Chi-square and student's &lt;i&gt;t&lt;/i&gt;-test were used to determine statistical significance, and a multivariable logistic regression determined the strength of associations.Of the 185...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/16q574bw</guid>
      <pubDate>Thu, 9 Oct 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Sarker, Minhazur</name>
      </author>
      <author>
        <name>Feiner, Rachel</name>
      </author>
      <author>
        <name>Canfield, Dana</name>
      </author>
      <author>
        <name>Kent, Madison</name>
      </author>
      <author>
        <name>Wiley, Rachel</name>
        <uri>https://orcid.org/0000-0003-2158-4482</uri>
      </author>
      <author>
        <name>Lamale-Smith, Leah</name>
        <uri>https://orcid.org/0000-0003-0572-3980</uri>
      </author>
      <author>
        <name>Teal, Elizabeth N</name>
      </author>
    </item>
    <item>
      <title>Real-world impact of COVID-19 vaccination, household exposure, and circulating SARS-CoV-2 variants on infection risk and symptom presentation in a U.S./Mexico border community</title>
      <link>https://escholarship.org/uc/item/96h426n1</link>
      <description>Background: San Ysidro, a densely populated primarily Latino community near the U.S./Mexico border, reported the highest rate of COVID-19 infection in San Diego County. In this increased infection risk environment, we explored the impact of COVID-19 vaccine status, household exposure, and primary circulating SARS-CoV-2 variant on the probability of infection and symptom presentation while controlling for temporal and sociodemographic factors.
Methods: Data were collected as part of CO-CREATE (Community-Driven Optimization of COVID-19 Testing to Reach and Engage underserved Areas for Testing Equity), a collaborative implementation study between University of California San Diego, a local Federally Qualified Health Center, and the Global Action Research Center. Self-reported sociodemographic factors, household exposure, vaccine status, and symptoms were extracted from a cross-sectional questionnaire completed by participants; PCR test results were used for analysis. Multi-level...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/96h426n1</guid>
      <pubDate>Thu, 28 Aug 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cohen, Ariel</name>
      </author>
      <author>
        <name>Reyes, Breanna</name>
      </author>
      <author>
        <name>Burola, Maria Linda</name>
      </author>
      <author>
        <name>Lomeli, Angel</name>
      </author>
      <author>
        <name>Escoto, Arleth A</name>
      </author>
      <author>
        <name>Salgin, Linda</name>
      </author>
      <author>
        <name>Rabin, Borsika A</name>
      </author>
      <author>
        <name>Stadnick, Nicole A</name>
        <uri>https://orcid.org/0000-0001-6520-2920</uri>
      </author>
      <author>
        <name>Zaslavsky, Ilya</name>
      </author>
      <author>
        <name>Tukey, Robert</name>
      </author>
      <author>
        <name>Laurent, Louise C</name>
      </author>
      <author>
        <name>Seifert, Marva</name>
        <uri>https://orcid.org/0000-0002-7554-6396</uri>
      </author>
    </item>
    <item>
      <title>Novel direct effect of CCR2 receptor on follicle activation process</title>
      <link>https://escholarship.org/uc/item/4qw7s32p</link>
      <description>Introduction: The regulation of primordial follicle activation is crucial for maintaining ovarian function, the duration of the reproductive phase, and fertility in women; therefore, we propose as our general objective to determine the physiological role of the chemokine receptor CCR2 within the follicular activation process.
Methods: Ovarian cortex fragments from adult domestic cats (&lt;i&gt;Felis catus&lt;/i&gt;) were cultured under different experimental groups: control (media alone), CCR2 antagonist (1µM), and recombinant chemokine CC-motif ligand 2 (CCL2) at two concentrations (10 ng/ml and 100 ng/ml) for 4 h or 48 h. At the end of the culture, the fragments were collected for RNA extraction, cDNA synthesis, and quantitative real-time PCR (4 h) or fixed and processed for paraffin embedding (48 h) for hematoxylin and eosin staining or immunohistochemistry for Ki67, bromodeoxyuridine (BrdU) and AKTp.
Results: Stimulation of CCR2 significantly increased the normalized mRNA expression of...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4qw7s32p</guid>
      <pubDate>Thu, 14 Aug 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Gamaleri, Yamila</name>
      </author>
      <author>
        <name>Ferman, Delfina Sol</name>
      </author>
      <author>
        <name>Ting, Alison</name>
      </author>
      <author>
        <name>Dascal, Eduardo Raúl</name>
      </author>
      <author>
        <name>Lomniczi, Alejandro</name>
      </author>
      <author>
        <name>Jaworski, Juan Pablo</name>
      </author>
      <author>
        <name>Peluffo, Marina Cinthia</name>
      </author>
    </item>
    <item>
      <title>55 MHz constant field dielectric warming of kidneys and ovaries cryopreserved by vitrification</title>
      <link>https://escholarship.org/uc/item/0wx8x9d0</link>
      <description>Organs cryopreserved by vitrification benefit from fast warming to avoid growth and recrystallization of ice that may nucleate during cooling and during warming. Rapid warming is especially important for tissue that doesn't absorb the full concentration of perfused cryoprotectants. Nanowarming uses an oscillating magnetic field to heat magnetic nanoparticles introduced into blood vessels during cryoprotectant perfusion. Dielectric warming uses an oscillating electric field to directly heat water and cryoprotectant molecules everywhere inside an organ. The efficiency of dielectric warming peaks at a particular solution viscosity and temperature that depends on the field oscillation frequency. Below that temperature, field uniformity is very important for uniform warming. An 800&amp;nbsp;W 55&amp;nbsp;MHz dielectric warming system was constructed that reached peak warming efficiency at -60&amp;nbsp;°C instead of -70&amp;nbsp;°C previously observed at 27&amp;nbsp;MHz when using the M22 vitrification...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0wx8x9d0</guid>
      <pubDate>Thu, 14 Aug 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Wowk, Brian</name>
      </author>
      <author>
        <name>Ting, Alison</name>
      </author>
      <author>
        <name>Phan, John</name>
      </author>
      <author>
        <name>Pagotan, Roberto</name>
      </author>
      <author>
        <name>Sharif, Adnan</name>
      </author>
      <author>
        <name>Chow, Limdo</name>
      </author>
      <author>
        <name>Fahy, Gregory M</name>
      </author>
    </item>
    <item>
      <title>Bacterial vaginosis toxins impair sperm capacitation and fertilization</title>
      <link>https://escholarship.org/uc/item/9vn1294n</link>
      <description>STUDY QUESTION: What effect do toxins produced by bacterial vaginosis (BV) bacteria have on sperm function?
SUMMARY ANSWER: BV toxins dysregulate sperm capacitation and intracellular calcium homeostasis, and impair the ability of sperm to fertilize oocytes.
WHAT IS KNOWN ALREADY: In BV, which is linked to infertility, overgrowth of Prevotella and Gardnerella in the vagina is accompanied by elevated concentrations of the toxins lipopolysaccharide (LPS) and vaginolysin (VLY).
STUDY DESIGN, SIZE, DURATION: This was a laboratory study in which human semen samples were collected from consenting healthy donors with normal semen parameters. Mouse sperm samples were obtained from the caudal epididymis.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Motile mouse and human sperm were isolated via swim-up and treated under non-capacitating or capacitating conditions. LPS from Escherichia coli was commercially available. VLY was produced by cloning the Gardnerella VLY protein in the ClearColi...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9vn1294n</guid>
      <pubDate>Fri, 1 Aug 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Bhagwat, Shweta</name>
      </author>
      <author>
        <name>Asadi, Leila</name>
      </author>
      <author>
        <name>McCarthy, Ronald</name>
      </author>
      <author>
        <name>Ferreira, Juan</name>
      </author>
      <author>
        <name>Li, Ping</name>
      </author>
      <author>
        <name>Li, Ethan</name>
      </author>
      <author>
        <name>Spivak, Sariela</name>
      </author>
      <author>
        <name>Gaydon, Ariana</name>
      </author>
      <author>
        <name>Reddy, Vaka</name>
      </author>
      <author>
        <name>Armstrong, Christy</name>
        <uri>https://orcid.org/0009-0009-1401-8651</uri>
      </author>
      <author>
        <name>Morrill, Sydney R</name>
      </author>
      <author>
        <name>Zhou, Hillary</name>
      </author>
      <author>
        <name>Lewis, Amanda L</name>
      </author>
      <author>
        <name>Lewis, Warren G</name>
      </author>
      <author>
        <name>Santi, Celia M</name>
      </author>
    </item>
    <item>
      <title>Understanding adaptations in a community-vetted COVID-19 testing program</title>
      <link>https://escholarship.org/uc/item/8z08f2nm</link>
      <description>Background: Adaptations are expected when complex public health interventions are implemented in dynamically and rapidly changing real-world settings, as seen for many programs during the COVID-19 pandemic. Systematic documentation of adaptations to intervention components and strategies are critical when assessing their impact on implementation. Here, we report processes used for tracking and evaluating adaptations made during the CO-CREATE project, which aimed to address COVID-19 testing disparities in the San Ysidro US/Mexico border community.
Methods: The study utilized a longitudinal, prospective, mixed methods approach to systematically document and assess adaptations across the pre-implementation, early and mid/late-implementation phases of the project. Aggregated from a combination of sources (i.e., meeting notes, Advisory Board transcripts, and periodic reflections), adaptations were entered weekly into an electronic database that captured information on 16 characteristics...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8z08f2nm</guid>
      <pubDate>Mon, 21 Jul 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Reyes, Breanna J</name>
      </author>
      <author>
        <name>Calvillo, Stephenie Tinoco</name>
      </author>
      <author>
        <name>Lomeli, Angel</name>
      </author>
      <author>
        <name>Escoto, Arleth A</name>
      </author>
      <author>
        <name>Burola, Maria Linda</name>
      </author>
      <author>
        <name>Cain, Kelli L</name>
      </author>
      <author>
        <name>Salgin, Linda</name>
      </author>
      <author>
        <name>Balbuena-Bojorquez, Maria</name>
      </author>
      <author>
        <name>Engler, Anne-Marie</name>
      </author>
      <author>
        <name>Seifert, Marva</name>
        <uri>https://orcid.org/0000-0002-7554-6396</uri>
      </author>
      <author>
        <name>Laurent, Louise C</name>
      </author>
      <author>
        <name>Stadnick, Nicole A</name>
        <uri>https://orcid.org/0000-0001-6520-2920</uri>
      </author>
      <author>
        <name>Rabin, Borsika A</name>
      </author>
    </item>
    <item>
      <title>Sustained dual delivery of metronidazole and viable Lactobacillus crispatus from 3D-printed silicone shells</title>
      <link>https://escholarship.org/uc/item/86r1d0vm</link>
      <description>Bacterial vaginosis (BV) is an imbalance of the vaginal microbiome in which there are limited lactobacilli and an overgrowth of anaerobic and fastidious bacteria such as Gardnerella. The propensity for BV recurrence is high, and therapies involving multiple treatment modalities are emerging to meet this need. However, current treatments requiring frequent therapeutic administration are challenging for patients and impact user compliance. Three-dimensional (3D)-printing offers a novel alternative to customize platforms to facilitate sustained therapeutic delivery to the vaginal tract. This study designed a novel vehicle intended for dual sustained delivery of both antibiotic and probiotic. 3D-printed compartmental scaffolds consisting of an antibiotic-containing silicone shell and a core containing probiotic Lactobacillus were developed with multiple formulations including biomaterials sodium alginate (SA), polyethylene glycol (PEG), polyvinyl alcohol (PVA), polyethylene oxide...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/86r1d0vm</guid>
      <pubDate>Wed, 11 Jun 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Kyser, Anthony J</name>
      </author>
      <author>
        <name>Mahmoud, Mohamed Y</name>
      </author>
      <author>
        <name>Fotouh, Bassam</name>
      </author>
      <author>
        <name>Patel, Rudra</name>
      </author>
      <author>
        <name>Armstrong, Christy</name>
        <uri>https://orcid.org/0009-0009-1401-8651</uri>
      </author>
      <author>
        <name>Aagard, Marnie</name>
      </author>
      <author>
        <name>Rush, Isaiah</name>
      </author>
      <author>
        <name>Lewis, Warren</name>
      </author>
      <author>
        <name>Lewis, Amanda</name>
      </author>
      <author>
        <name>Frieboes, Hermann B</name>
      </author>
    </item>
    <item>
      <title>Preclinical validation of electrospun fibers to achieve vaginal colonization by Lactobacillus crispatus</title>
      <link>https://escholarship.org/uc/item/2mg9c6tg</link>
      <description>Communities of bacteria collectively known as the vaginal microbiota reside in the human vagina. Bacterial vaginosis (BV) describes an imbalance of this microbiota, affecting more than 25% of women worldwide, and is linked to health problems such as infertility, cervical cancer, and preterm birth. Following antibiotic treatment, BV becomes recurrent in many individuals. &lt;i&gt;Lactobacillus crispatus&lt;/i&gt; is widely believed to contribute to a healthy vaginal microbiome, and its therapeutic application has shown promise in early clinical trials investigating adjunct therapies for lasting treatment of conditions such as BV. There is a pressing need for therapeutic platforms that apply biologically active agents such as probiotic bacteria, to the vagina with little user effort but lasting effect. Here, we use a mouse model to investigate the functional utility and potential harms of soft, slow-dissolving fibers made by electrospinning polyethylene oxide (PEO) and poly(lactic-&lt;i&gt;co&lt;/i&gt;-glycolic...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2mg9c6tg</guid>
      <pubDate>Wed, 11 Jun 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Armstrong, Christy N</name>
        <uri>https://orcid.org/0009-0009-1401-8651</uri>
      </author>
      <author>
        <name>Saha, Sudeshna</name>
      </author>
      <author>
        <name>Aagard, Marnie A</name>
      </author>
      <author>
        <name>Mahmoud, Mohamed Y</name>
      </author>
      <author>
        <name>Varki, Nissi M</name>
      </author>
      <author>
        <name>Gilbert, Nicole M</name>
      </author>
      <author>
        <name>Frieboes, Hermann B</name>
      </author>
      <author>
        <name>Lewis, Warren G</name>
      </author>
      <author>
        <name>Lewis, Amanda L</name>
      </author>
    </item>
    <item>
      <title>Nulliparous with Class III Obesity at Term: Labor Induction or Cesarean Delivery without Labor</title>
      <link>https://escholarship.org/uc/item/70k8c8wk</link>
      <description>OBJECTIVE:  This study aimed to compare maternal and neonatal outcomes between labor induction versus cesarean delivery (CD) without labor among nulliparous individuals with class III obesity (body mass index [BMI] ≥40 kg/m&lt;sup&gt;2&lt;/sup&gt;).
STUDY DESIGN:  A retrospective cohort study of all nulliparous singleton deliveries at ≥37 weeks with a BMI of ≥40 kg/m&lt;sup&gt;2&lt;/sup&gt; at delivery between March 2020 and February 2022. We excluded individuals with spontaneous labor, fetal malformations, and stillbirths. The primary outcome was a composite of maternal mortality and morbidity, including infectious and hemorrhagic morbidity. The secondary outcome was a neonatal composite. A subgroup analysis evaluated patients with a BMI of ≥50 kg/m&lt;sup&gt;2&lt;/sup&gt;. Another subgroup analysis compared outcomes between CD without labor and an indicated CD following induction. A multivariable logistic regression was applied. For adjustment, we used possible confounders identified in a univariate analysis.
RESULTS:...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/70k8c8wk</guid>
      <pubDate>Thu, 5 Jun 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Bart, Yossi</name>
      </author>
      <author>
        <name>Wiley, Rachel L</name>
        <uri>https://orcid.org/0000-0003-2158-4482</uri>
      </author>
      <author>
        <name>Ghose, Ipsita</name>
      </author>
      <author>
        <name>Bartal, Michal Fishel</name>
      </author>
      <author>
        <name>Chahine, Khalil M</name>
      </author>
      <author>
        <name>Chauhan, Suneet P</name>
      </author>
      <author>
        <name>Blackwell, Sean</name>
      </author>
      <author>
        <name>Sibai, Baha M</name>
      </author>
    </item>
    <item>
      <title>Phylogeographic and genetic network assessment of COVID-19 mitigation protocols on SARS-CoV-2 transmission in university campus residences</title>
      <link>https://escholarship.org/uc/item/9t12820z</link>
      <description>BACKGROUND: Congregate living provides an ideal setting for SARS-CoV-2 transmission in which many outbreaks and superspreading events occurred. To avoid large outbreaks, universities turned to remote operations during the initial COVID-19 pandemic waves in 2020 and 2021. In late-2021, the University of California San Diego (UC San Diego) facilitated the return of students to campus with comprehensive testing, vaccination, masking, wastewater surveillance, and isolation policies.
METHODS: We performed molecular epidemiological and phylogeographic analysis of 4418 SARS-CoV-2 genomes sampled from UC San Diego students during the Omicron waves between December 2021 and September 2022, representing 58% of students with confirmed SARS-CoV-2 infection. We overlaid these analyses across on-campus residential information to assess the spread and persistence of SARS-CoV-2 within university residences.
FINDINGS: Within campus residences, SARS-CoV-2 transmission was frequent among students...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9t12820z</guid>
      <pubDate>Thu, 22 May 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Wertheim, Joel O</name>
      </author>
      <author>
        <name>Vasylyeva, Tetyana I</name>
        <uri>https://orcid.org/0000-0002-9736-7022</uri>
      </author>
      <author>
        <name>Wood, Robert J</name>
      </author>
      <author>
        <name>Cantrell, Kalen</name>
      </author>
      <author>
        <name>Contreras, Soraya Piña</name>
      </author>
      <author>
        <name>Feldheim, Aryeh</name>
      </author>
      <author>
        <name>Goyal, Ravi</name>
        <uri>https://orcid.org/0000-0002-0358-2435</uri>
      </author>
      <author>
        <name>Havens, Jennifer L</name>
      </author>
      <author>
        <name>Knight, Rob</name>
        <uri>https://orcid.org/0000-0002-0975-9019</uri>
      </author>
      <author>
        <name>Laurent, Louise C</name>
        <uri>https://orcid.org/0000-0002-2095-7534</uri>
      </author>
      <author>
        <name>Moshiri, Niema</name>
        <uri>https://orcid.org/0000-0003-2209-8128</uri>
      </author>
      <author>
        <name>Neuhard, Robert</name>
      </author>
      <author>
        <name>Sathe, Shashank</name>
      </author>
      <author>
        <name>Satterlund, Alysson</name>
      </author>
      <author>
        <name>Scioscia, Angela</name>
      </author>
      <author>
        <name>Song, Angela Y</name>
      </author>
      <author>
        <name>Alliance, SEARCH</name>
      </author>
      <author>
        <name>Aigner, Stefan</name>
        <uri>https://orcid.org/0000-0002-9511-3328</uri>
      </author>
      <author>
        <name>Andersen, Kristian G</name>
      </author>
      <author>
        <name>Baer, Nathan A</name>
      </author>
      <author>
        <name>Betty, Maryann</name>
      </author>
      <author>
        <name>Birmingham, Amanda</name>
        <uri>https://orcid.org/0000-0002-4117-3317</uri>
      </author>
      <author>
        <name>Castro-Martinez, Anelizze</name>
      </author>
      <author>
        <name>Cheung, Willi</name>
      </author>
      <author>
        <name>De Hoff, Peter</name>
      </author>
      <author>
        <name>Fisch, Kathleen M</name>
        <uri>https://orcid.org/0000-0002-0117-7444</uri>
      </author>
      <author>
        <name>King, Alison J</name>
      </author>
      <author>
        <name>Gangavarapu, Karthik</name>
      </author>
      <author>
        <name>Hakim, Abbas</name>
      </author>
      <author>
        <name>Henson, Benjamin</name>
      </author>
      <author>
        <name>Jepsen, Kristen</name>
      </author>
      <author>
        <name>Mac, Christina H</name>
      </author>
      <author>
        <name>Ngo, Toan T</name>
      </author>
      <author>
        <name>Nguyen, Kelly N</name>
      </author>
      <author>
        <name>Ostrander, Tyler R</name>
      </author>
      <author>
        <name>Perkins, Sarah</name>
      </author>
      <author>
        <name>Plascencia, Ashley</name>
      </author>
      <author>
        <name>Rivera, Andrea</name>
      </author>
      <author>
        <name>Rivera, Ariana</name>
        <uri>https://orcid.org/0009-0001-8732-8863</uri>
      </author>
      <author>
        <name>Salido, Rodolfo A</name>
      </author>
      <author>
        <name>Saucedo, Kieran C</name>
      </author>
      <author>
        <name>Schwab, Madison</name>
      </author>
      <author>
        <name>Steedman, Allison L</name>
      </author>
      <author>
        <name>Veder, Anthony</name>
        <uri>https://orcid.org/0009-0000-6708-9538</uri>
      </author>
      <author>
        <name>Weiss, Alana</name>
      </author>
      <author>
        <name>Yeo, Gene W</name>
      </author>
      <author>
        <name>Zeller, Mark</name>
      </author>
      <author>
        <name>Schooley, Robert T</name>
      </author>
      <author>
        <name>Anderson, Cheryl M</name>
      </author>
      <author>
        <name>Martin, Natasha K</name>
      </author>
    </item>
    <item>
      <title>Wastewater-integrated pathogen surveillance dashboards enable real-time, transparent, and interpretable public health risk assessment and dissemination</title>
      <link>https://escholarship.org/uc/item/8n39p0qj</link>
      <description>Timely pathogen surveillance and reporting is essential for effective public health guidance. Web dashboards have become a key tool for communicating public health information to stakeholders, health care workers, and the broader community. Over the SARS-CoV-2 pandemic, wastewater surveillance has increasingly been incorporated into public health workflows for outbreak monitoring and response, enabling community-representative and low-cost monitoring to supplement clinical surveillance. However, the methods used for visualization and dissemination of clinical and wastewater surveillance data differ across programs, and best practices are yet to be defined. In this work, we demonstrate data workflows and dashboards used to perform wastewater-based public health surveillance in tandem with clinical data across local and national scales, leveraging custom-built, reproducible, and open-source software. Using a centralized data aggregation and analysis hub approach, we establish multiple...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8n39p0qj</guid>
      <pubDate>Thu, 22 May 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Msomi, Nosihle S</name>
      </author>
      <author>
        <name>Levy, Joshua I</name>
      </author>
      <author>
        <name>Matteson, Nathaniel L</name>
      </author>
      <author>
        <name>Ndlovu, Nkosenhle</name>
      </author>
      <author>
        <name>Ntuli, Phindile</name>
      </author>
      <author>
        <name>Baer, Adam</name>
      </author>
      <author>
        <name>Pilz, Dylan</name>
      </author>
      <author>
        <name>Mabasa, Victor</name>
      </author>
      <author>
        <name>Gwala, Sipho</name>
      </author>
      <author>
        <name>Singh, Natasha</name>
      </author>
      <author>
        <name>Subramoney, Kathleen</name>
      </author>
      <author>
        <name>Phalane, Emmanuel</name>
      </author>
      <author>
        <name>Macheke, Mokgaetji</name>
      </author>
      <author>
        <name>Motloung, Mantshali</name>
      </author>
      <author>
        <name>Mangena, Thabo</name>
      </author>
      <author>
        <name>Monametsi, Lethabo</name>
      </author>
      <author>
        <name>Rabotapi, Lebohang</name>
      </author>
      <author>
        <name>Maposa, Sibonginkosi</name>
      </author>
      <author>
        <name>Birmingham, Amanda</name>
        <uri>https://orcid.org/0000-0002-4117-3317</uri>
      </author>
      <author>
        <name>Zeller, Mark</name>
      </author>
      <author>
        <name>Karthikeyan, Smruthi</name>
      </author>
      <author>
        <name>De Hoff, Peter</name>
      </author>
      <author>
        <name>Harris, Simon</name>
      </author>
      <author>
        <name>Knight, Rob</name>
        <uri>https://orcid.org/0000-0002-0975-9019</uri>
      </author>
      <author>
        <name>Laurent, Louise C</name>
        <uri>https://orcid.org/0000-0002-2095-7534</uri>
      </author>
      <author>
        <name>Andersen, Kristian G</name>
      </author>
      <author>
        <name>McCarthy, Kerrigan</name>
      </author>
      <author>
        <name>Yousif, Mukhlid</name>
      </author>
    </item>
    <item>
      <title>Impact of mismatch repair (MMR) status on recurrence in high intermediate risk endometrial cancer</title>
      <link>https://escholarship.org/uc/item/4q41w520</link>
      <description>BACKGROUND: Approximately 25&amp;nbsp;% of endometrial cancers harbor deficiencies in mismatch repair (dMMR). The clinical impact of this molecular aberration remains undefined in patients with high intermediate risk (HIR) endometrial cancer.
METHODS: We conducted a retrospective chart review of women diagnosed with Stage I high-intermediate risk endometrioid endometrial cancer in two hospital systems in Southern California between 2016 and 2018. We collected demographic information, mismatch repair status, pathology reports, and time to recurrence.
RESULTS: 244 patients met inclusion criteria, of which 86 (35&amp;nbsp;%) were found to be dMMR. The dMMR patient population had higher relative risks of lymphovascular space invasion (relative risk 1.63, 95&amp;nbsp;% confidence interval 1.26-2.10, p-value 0.0002) but were less likely to have deep myometrial invasion (relative risk 0.81, 95&amp;nbsp;% confidence interval 0.66-0.99, p-value 0.047) when compared to the pMMR EC cohort. No differences...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4q41w520</guid>
      <pubDate>Thu, 22 May 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Keverline, Kelsey Jean</name>
      </author>
      <author>
        <name>Hill, Breana</name>
      </author>
      <author>
        <name>Hom-Tedla, Marianne</name>
      </author>
      <author>
        <name>Jacobs, Marni</name>
      </author>
      <author>
        <name>Eskander, Ramez N</name>
      </author>
    </item>
    <item>
      <title>OC 33.2 Maladaptive Lymphangiogenesis is Associated with Synovial Iron Accumulation and Delayed Clearance in FVIII-/- Mice After Induced Hemarthrosis</title>
      <link>https://escholarship.org/uc/item/4rm2w9wg</link>
      <description>OC 33.2 Maladaptive Lymphangiogenesis is Associated with Synovial Iron Accumulation and Delayed Clearance in FVIII-/- Mice After Induced Hemarthrosis</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4rm2w9wg</guid>
      <pubDate>Thu, 24 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Joseph, B Chumappumkal</name>
      </author>
      <author>
        <name>Cooke, E</name>
      </author>
      <author>
        <name>Nasamran, C</name>
      </author>
      <author>
        <name>Fisch, K</name>
        <uri>https://orcid.org/0000-0002-0117-7444</uri>
      </author>
      <author>
        <name>von Drygalski, A</name>
      </author>
    </item>
    <item>
      <title>Gut bacterial lactate stimulates lung epithelial mitochondria and exacerbates acute lung injury</title>
      <link>https://escholarship.org/uc/item/37k5g7r1</link>
      <description>Acute respiratory distress syndrome (ARDS) is an often fatal critical illness where lung epithelial injury leads to intrapulmonary fluid accumulation. ARDS became widespread during the COVID-19 pandemic, motivating a renewed effort to understand the complex etiology of this disease. Rigorous prior work has implicated lung endothelial and epithelial injury in response to an insult such as bacterial infection; however, the impact of microorganisms found in other organs on ARDS remains unclear. Here, we use a combination of gnotobiotic mice, cell culture experiments, and re-analyses of a large metabolomics dataset from ARDS patients to reveal that gut bacteria impact lung cellular respiration by releasing metabolites that alter mitochondrial activity in lung epithelium. Colonization of germ-free mice with a complex gut microbiota stimulated lung mitochondrial gene expression. A single human gut bacterial species, &lt;i&gt;Bifidobacterium adolescentis,&lt;/i&gt; was sufficient to replicate this...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/37k5g7r1</guid>
      <pubDate>Thu, 24 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Upadhyay, Vaibhav</name>
      </author>
      <author>
        <name>Ortega, Edwin F</name>
      </author>
      <author>
        <name>Hernandez, Luis A Ramirez</name>
      </author>
      <author>
        <name>Alexander, Margaret</name>
      </author>
      <author>
        <name>Kaur, Gagandeep</name>
      </author>
      <author>
        <name>Trepka, Kai</name>
        <uri>https://orcid.org/0000-0002-8672-6317</uri>
      </author>
      <author>
        <name>Rock, Rachel R</name>
      </author>
      <author>
        <name>Shima, Rafaella T</name>
      </author>
      <author>
        <name>Cheshire, W Colby</name>
      </author>
      <author>
        <name>Alipanah-Lechner, Narges</name>
        <uri>https://orcid.org/0000-0002-8381-5701</uri>
      </author>
      <author>
        <name>Calfee, Carolyn S</name>
      </author>
      <author>
        <name>Matthay, Michael A</name>
      </author>
      <author>
        <name>Lee, Joyce V</name>
      </author>
      <author>
        <name>Goga, Andrei</name>
      </author>
      <author>
        <name>Jain, Isha H</name>
      </author>
      <author>
        <name>Turnbaugh, Peter J</name>
        <uri>https://orcid.org/0000-0002-0888-2875</uri>
      </author>
    </item>
    <item>
      <title>Increasing capacity for ethnically-based community leaders to engage in policy change: assessing the impact of a train-the-trainer approach</title>
      <link>https://escholarship.org/uc/item/08n901fk</link>
      <description>BackgroundThe COVID-19 pandemic exacerbated existing disparities in healthcare access and outcomes, particularly among underserved communities. As one site participating in the NIH-funded Community Engagement Alliance Against COVID-19, our focus was to address COVID-19 disparities by training immigrant and refugee communities to advocate for their needs by increasing capacity to campaign for policy-level changes.ObjectiveTo evaluate the impact of a train-the-trainer policy advocacy program for ethnically-based community leaders within San Diego County using a mixed-methods evaluation.MethodsWe partnered with a non-profit social change, intermediary organization to adapt a five-session, 4-hour per session training that was conducted over five weeks. A baseline survey, pre-&amp;nbsp;and post-training surveys, and ethnographic documentation were employed during each session.ResultsAmong participants (n = 16), 50% were Latino(a), 25% were Somali Bantu, and 25% were Karen. Training results...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/08n901fk</guid>
      <pubDate>Sat, 19 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Lomeli, Angel</name>
      </author>
      <author>
        <name>Stadnick, Nicole A</name>
        <uri>https://orcid.org/0000-0001-6520-2920</uri>
      </author>
      <author>
        <name>Cain, Kelli L</name>
      </author>
      <author>
        <name>Watson, Paul</name>
      </author>
      <author>
        <name>Oswald, William</name>
      </author>
      <author>
        <name>Broyles, Shelia L</name>
      </author>
      <author>
        <name>Ibarra, Marina</name>
      </author>
      <author>
        <name>Rabin, Borsika</name>
      </author>
    </item>
    <item>
      <title>Considerations for prenatal and postpartum management of a female patient with ornithine transcarbamylase deficiency</title>
      <link>https://escholarship.org/uc/item/5qq5m6vf</link>
      <description>We report on pregnancy management and outcomes in a 27-year-old female patient with ornithine transcarbamylase (OTC) deficiency, the most common inherited enzyme deficiency in the urea cycle. Our patient was diagnosed during childhood after hyperammonemia associated with surgery and steroid treatment and was well-controlled with nitrogen scavenger treatment, low-protein diet, and L-citrulline supplementation. &lt;i&gt;OTC&lt;/i&gt; gene sequencing identified a variant of unknown significance that has more recently been classified as likely pathogenic. Women with OTC deficiency are at increased risk of hyperammonemia during pregnancy and the postpartum period, therefore monthly follow up and laboratory assessments are critical in management decision making. Our patient was maintained on glycerol phenylbutyrate, L-citrulline and essential amino acid supplements, along with restricted protein intake during pregnancy. A multidisciplinary approach with the obstetrics, prenatal genetics, high risk...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5qq5m6vf</guid>
      <pubDate>Fri, 11 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Feigenbaum, Annette</name>
        <uri>https://orcid.org/0000-0002-7918-1670</uri>
      </author>
      <author>
        <name>Lamale-Smith, Leah</name>
        <uri>https://orcid.org/0000-0003-0572-3980</uri>
      </author>
      <author>
        <name>Weinstein, Lawrence</name>
      </author>
    </item>
    <item>
      <title>Prospermatogonia</title>
      <link>https://escholarship.org/uc/item/3xw3v6f5</link>
      <description>Prospermatogonia</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3xw3v6f5</guid>
      <pubDate>Thu, 10 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Wilkinson, Miles F</name>
      </author>
      <author>
        <name>Tan, Kun</name>
        <uri>https://orcid.org/0000-0002-8567-7795</uri>
      </author>
    </item>
    <item>
      <title>Extracellular microRNAs associated with psychiatric symptoms in the Normative Aging Study</title>
      <link>https://escholarship.org/uc/item/67z926d2</link>
      <description>Earlier studies have revealed microRNAs (miRNAs) as potential biomarkers for neurological conditions, however, such evidence on psychiatric outcomes is limited. We utilized the Normative Aging Study (NAS) cohort to investigate the associations between extracellular miRNAs (ex-miRNA) and psychiatric symptoms among a group of older male adults, along with the targeted genes and biological pathways. We studied 569 participants with miRNA profile primarily measured in extracellular vesicles isolated from plasma, and psychiatric symptoms reported over 1996-2014 with repeated measures. Global and dimension scales of psychiatric symptoms were measured via the administration of Brief Symptom Inventory (BSI) per visit covering nine aspects of psychiatric health, such as anxiety, depression, hostility, psychoticism, etc. Ex-miRNAs were profiled using small RNA sequencing. Associations of expression of 395 ex-miRNAs (present in &amp;gt;70% samples) with current mental status were assessed using...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/67z926d2</guid>
      <pubDate>Mon, 7 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Qiu, Xinye</name>
      </author>
      <author>
        <name>Danesh Yazdi, Mahdieh</name>
      </author>
      <author>
        <name>Wang, Cuicui</name>
      </author>
      <author>
        <name>Kosheleva, Anna</name>
      </author>
      <author>
        <name>Wu, Haotian</name>
      </author>
      <author>
        <name>Vokonas, Pantel S</name>
      </author>
      <author>
        <name>Spiro, Avron</name>
      </author>
      <author>
        <name>Laurent, Louise C</name>
        <uri>https://orcid.org/0000-0002-2095-7534</uri>
      </author>
      <author>
        <name>DeHoff, Peter</name>
      </author>
      <author>
        <name>Kubzansky, Laura D</name>
      </author>
      <author>
        <name>Weisskopf, Marc G</name>
      </author>
      <author>
        <name>Baccarelli, Andrea A</name>
      </author>
      <author>
        <name>Schwartz, Joel D</name>
      </author>
    </item>
    <item>
      <title>Inhibition of human-HPV hybrid ecDNA enhancers reduces oncogene expression and tumor growth in oropharyngeal cancer</title>
      <link>https://escholarship.org/uc/item/4sr5f3nr</link>
      <description>Extrachromosomal circular DNA (ecDNA) has been found in most types of human cancers, and ecDNA incorporating viral genomes has recently been described, specifically in human papillomavirus (HPV)-mediated oropharyngeal cancer (OPC). However, the molecular mechanisms of human-viral hybrid ecDNA (hybrid ecDNA) for carcinogenesis remains elusive. We characterize the epigenetic status of hybrid ecDNA using HPVOPC cell lines and patient-derived tumor xenografts, identifying HPV oncogenes E6/E7 in hybrid ecDNA are flanked by previously unrecognized somatic DNA enhancers and HPV L1 enhancers, with strong cis-interactions. Targeting of these enhancers by clustered regularly interspaced short palindromic repeats interference or hybrid ecDNA by bromodomain and extra-terminal inhibitor reduces E6/E7 expression, and significantly inhibites in vitro and/or in vivo growth only in ecDNA(+) models. HPV DNA in hybrid ecDNA structures are associated with previously unrecognized somatic and HPV enhancers...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4sr5f3nr</guid>
      <pubDate>Fri, 4 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Nakagawa, Takuya</name>
      </author>
      <author>
        <name>Luebeck, Jens</name>
      </author>
      <author>
        <name>Zhu, Kaiyuan</name>
      </author>
      <author>
        <name>Lange, Joshua T</name>
      </author>
      <author>
        <name>Sasik, Roman</name>
      </author>
      <author>
        <name>Phillips, Chad</name>
      </author>
      <author>
        <name>Sadat, Sayed</name>
      </author>
      <author>
        <name>Javadzadeh, Sara</name>
      </author>
      <author>
        <name>Yang, Qian</name>
      </author>
      <author>
        <name>Monther, Abdula</name>
      </author>
      <author>
        <name>Fassardi, Santiago</name>
      </author>
      <author>
        <name>Wang, Allen</name>
      </author>
      <author>
        <name>Pestonjamasp, Kersi</name>
      </author>
      <author>
        <name>Rosenthal, Brin</name>
      </author>
      <author>
        <name>Fisch, Kathleen M</name>
        <uri>https://orcid.org/0000-0002-0117-7444</uri>
      </author>
      <author>
        <name>Mischel, Paul</name>
      </author>
      <author>
        <name>Bafna, Vineet</name>
        <uri>https://orcid.org/0000-0002-5810-6241</uri>
      </author>
      <author>
        <name>Califano, Joseph A</name>
      </author>
    </item>
    <item>
      <title>Themis suppresses the effector function of CD8+ T cells in acute viral infection</title>
      <link>https://escholarship.org/uc/item/19w4p4cn</link>
      <description>CD8+ T cells play a central role in antiviral immune responses. Upon infection, naive CD8+ T cells differentiate into effector cells to eliminate virus-infected cells, and some of these effector cells further differentiate into memory cells to provide long-term protection after infection is resolved. Although extensively investigated, the underlying mechanisms of CD8+ T-cell differentiation remain incompletely understood. Themis is a T-cell-specific protein that plays critical roles in T-cell development. Recent studies using Themis T-cell conditional knockout mice also demonstrated that Themis is required to promote mature CD8+ T-cell homeostasis, cytokine responsiveness, and antibacterial responses. In this study, we used LCMV Armstrong infection as a probe to explore the role of Themis in viral infection. We found that preexisting CD8+ T-cell homeostasis defects and cytokine hyporesponsiveness do not impair viral clearance in Themis T-cell conditional knockout mice. Further...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/19w4p4cn</guid>
      <pubDate>Fri, 4 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Tang, Jian</name>
      </author>
      <author>
        <name>Jia, Xian</name>
      </author>
      <author>
        <name>Li, Jian</name>
      </author>
      <author>
        <name>Dong, Junchen</name>
      </author>
      <author>
        <name>Wang, Jiayu</name>
      </author>
      <author>
        <name>Li, Wanyun</name>
      </author>
      <author>
        <name>Zhu, Yuzhen</name>
      </author>
      <author>
        <name>Hu, Yanyan</name>
      </author>
      <author>
        <name>Hou, Bowen</name>
      </author>
      <author>
        <name>Lin, Chunjie</name>
      </author>
      <author>
        <name>Cong, Yu</name>
      </author>
      <author>
        <name>Ren, Tong</name>
      </author>
      <author>
        <name>Yan, Changsheng</name>
      </author>
      <author>
        <name>Yang, Hongying</name>
      </author>
      <author>
        <name>Lai, Qian</name>
      </author>
      <author>
        <name>Zheng, Haiping</name>
      </author>
      <author>
        <name>Bao, Yuzhou</name>
      </author>
      <author>
        <name>Gautam, Namrata</name>
      </author>
      <author>
        <name>Wang, Hong-Rui</name>
      </author>
      <author>
        <name>Xu, Bing</name>
      </author>
      <author>
        <name>Chen, Xiao Lei</name>
        <uri>https://orcid.org/0000-0001-7998-9963</uri>
      </author>
      <author>
        <name>Li, Qing</name>
      </author>
      <author>
        <name>Gascoigne, Nicholas RJ</name>
      </author>
      <author>
        <name>Fu, Guo</name>
      </author>
    </item>
    <item>
      <title>Preclinical evaluation of a regimen combining chidamide and ABT-199 in acute myeloid leukemia</title>
      <link>https://escholarship.org/uc/item/7ph9426t</link>
      <description>Acute myeloid leukemia (AML) is a heterogeneous myeloid neoplasm with poor clinical outcome, despite the great progress in treatment in recent years. The selective Bcl-2 inhibitor venetoclax (ABT-199) in combination therapy has been approved for the treatment of newly diagnosed AML patients who are ineligible for intensive chemotherapy, but resistance can be acquired through the upregulation of alternative antiapoptotic proteins. Here, we reported that a newly emerged histone deacetylase inhibitor, chidamide (CS055), at low-cytotoxicity dose enhanced the anti-AML activity of ABT-199, while sparing normal hematopoietic progenitor cells. Moreover, we also found that chidamide showed a superior resensitization effect than romidepsin in potentiation of ABT-199 lethality. Inhibition of multiple HDACs rather than some single component might be required. The combination therapy was also effective in primary AML blasts and stem/progenitor cells regardless of disease status and genetic...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7ph9426t</guid>
      <pubDate>Thu, 27 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Chen, Kai</name>
      </author>
      <author>
        <name>Yang, Qianying</name>
      </author>
      <author>
        <name>Zha, Jie</name>
      </author>
      <author>
        <name>Deng, Manman</name>
      </author>
      <author>
        <name>Zhou, Yong</name>
      </author>
      <author>
        <name>Fu, Guofeng</name>
      </author>
      <author>
        <name>Bi, Silei</name>
      </author>
      <author>
        <name>Feng, Liying</name>
      </author>
      <author>
        <name>Xu-Monette, Zijun Y</name>
      </author>
      <author>
        <name>Chen, Xiao Lei</name>
        <uri>https://orcid.org/0000-0001-7998-9963</uri>
      </author>
      <author>
        <name>Fu, Guo</name>
      </author>
      <author>
        <name>Dai, Yun</name>
      </author>
      <author>
        <name>Young, Ken H</name>
      </author>
      <author>
        <name>Xu, Bing</name>
      </author>
    </item>
    <item>
      <title>Risk of meningomyelocele mediated by the common 22q11.2 deletion</title>
      <link>https://escholarship.org/uc/item/992849kp</link>
      <description>Meningomyelocele is one of the most severe forms of neural tube defects (NTDs) and the most frequent structural birth defect of the central nervous system. We assembled the Spina Bifida Sequencing Consortium to identify causes. Exome and genome sequencing of 715 parent-offspring trios identified six patients with chromosomal 22q11.2 deletions, suggesting a 23-fold increased risk compared with the general population. Furthermore, analysis of a separate 22q11.2 deletion cohort suggested a 12- to 15-fold increased NTD risk of meningomyelocele. The loss of &lt;i&gt;Crkl&lt;/i&gt;, one of several neural tube-expressed genes within the minimal deletion interval, was sufficient to replicate NTDs in mice, where both penetrance and expressivity were exacerbated by maternal folate deficiency. Thus, the common 22q11.2 deletion confers substantial meningomyelocele risk, which is partially alleviated by folate supplementation.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/992849kp</guid>
      <pubDate>Fri, 21 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Vong, Keng Ioi</name>
      </author>
      <author>
        <name>Lee, Sangmoon</name>
      </author>
      <author>
        <name>Au, Kit Sing</name>
      </author>
      <author>
        <name>Crowley, T Blaine</name>
      </author>
      <author>
        <name>Capra, Valeria</name>
      </author>
      <author>
        <name>Martino, Jeremiah</name>
      </author>
      <author>
        <name>Haller, Meade</name>
      </author>
      <author>
        <name>Araújo, Camila</name>
      </author>
      <author>
        <name>Machado, Hélio R</name>
      </author>
      <author>
        <name>George, Renee</name>
      </author>
      <author>
        <name>Gerding, Bryn</name>
      </author>
      <author>
        <name>James, Kiely N</name>
      </author>
      <author>
        <name>Stanley, Valentina</name>
        <uri>https://orcid.org/0000-0002-2212-7796</uri>
      </author>
      <author>
        <name>Jiang, Nan</name>
      </author>
      <author>
        <name>Alu, Kameron</name>
      </author>
      <author>
        <name>Meave, Naomi</name>
      </author>
      <author>
        <name>Nidhiry, Anna S</name>
      </author>
      <author>
        <name>Jiwani, Fiza</name>
      </author>
      <author>
        <name>Tang, Isaac</name>
      </author>
      <author>
        <name>Nisal, Ashna</name>
      </author>
      <author>
        <name>Jhamb, Ishani</name>
      </author>
      <author>
        <name>Patel, Arzoo</name>
      </author>
      <author>
        <name>Patel, Aakash</name>
      </author>
      <author>
        <name>McEvoy-Venneri, Jennifer</name>
      </author>
      <author>
        <name>Barrows, Chelsea</name>
      </author>
      <author>
        <name>Shen, Celina</name>
        <uri>https://orcid.org/0009-0001-1761-5592</uri>
      </author>
      <author>
        <name>Ha, Yoo-Jin</name>
      </author>
      <author>
        <name>Howarth, Robyn</name>
      </author>
      <author>
        <name>Strain, Madison</name>
      </author>
      <author>
        <name>Ashley-Koch, Allison Elizabeth</name>
      </author>
      <author>
        <name>Azam, Matloob</name>
      </author>
      <author>
        <name>Mumtaz, Sara</name>
      </author>
      <author>
        <name>Bot, Gyang Markus</name>
      </author>
      <author>
        <name>Finnell, Richard H</name>
      </author>
      <author>
        <name>Kibar, Zoha</name>
      </author>
      <author>
        <name>Marwan, Ahmed I</name>
      </author>
      <author>
        <name>Melikishvili, Gia</name>
      </author>
      <author>
        <name>Meltzer, Hal S</name>
      </author>
      <author>
        <name>Mutchinick, Osvaldo M</name>
      </author>
      <author>
        <name>Stevenson, David A</name>
      </author>
      <author>
        <name>Mroczkowski, Henry J</name>
      </author>
      <author>
        <name>Ostrander, Betsy</name>
      </author>
      <author>
        <name>Schindewolf, Erica</name>
      </author>
      <author>
        <name>Moldenhauer, Julie</name>
      </author>
      <author>
        <name>Zackai, Elaine H</name>
      </author>
      <author>
        <name>Emanuel, Beverly S</name>
      </author>
      <author>
        <name>Garcia-Minaur, Sixto</name>
      </author>
      <author>
        <name>Nowakowska, Beata A</name>
      </author>
      <author>
        <name>Stevenson, Roger E</name>
      </author>
      <author>
        <name>Zaki, Maha S</name>
      </author>
      <author>
        <name>Northrup, Hope</name>
      </author>
      <author>
        <name>McNamara, Hanna K</name>
      </author>
      <author>
        <name>Aldinger, Kimberly A</name>
      </author>
      <author>
        <name>Phelps, Ian G</name>
      </author>
      <author>
        <name>Deng, Mei</name>
      </author>
      <author>
        <name>Glass, Ian A</name>
      </author>
      <author>
        <name>Morrow, Bernice</name>
      </author>
      <author>
        <name>McDonald-McGinn, Donna M</name>
      </author>
      <author>
        <name>Sanna-Cherchi, Simone</name>
      </author>
      <author>
        <name>Lamb, Dolores J</name>
      </author>
      <author>
        <name>Gleeson, Joseph G</name>
      </author>
      <author>
        <name>Koch, Allison Elizabeth Ashley</name>
      </author>
      <author>
        <name>Meltzer, Hal S</name>
      </author>
      <author>
        <name>Le, Joan</name>
      </author>
      <author>
        <name>Au, Kit Sing</name>
      </author>
      <author>
        <name>Northrup, Hope</name>
      </author>
      <author>
        <name>Bot, Gyang Markus</name>
      </author>
      <author>
        <name>Capra, Valeria</name>
      </author>
      <author>
        <name>Finnell, Richard H</name>
      </author>
      <author>
        <name>Kibar, Zoha</name>
      </author>
      <author>
        <name>Lupo, Philip J</name>
      </author>
      <author>
        <name>Machado, Helio R</name>
      </author>
      <author>
        <name>Araújo, Camila</name>
      </author>
      <author>
        <name>Magana, Tony</name>
      </author>
      <author>
        <name>Marwan, Ahmed I</name>
      </author>
      <author>
        <name>Melikishvili, Gia</name>
      </author>
      <author>
        <name>Mutchinick, Osvaldo M</name>
      </author>
      <author>
        <name>Stevenson, Roger E</name>
      </author>
      <author>
        <name>Yurrita, Anna</name>
      </author>
      <author>
        <name>Zaki, Maha S</name>
      </author>
      <author>
        <name>Mumtaz, Sara</name>
      </author>
      <author>
        <name>Medina-Bereciartu, José Ramón</name>
      </author>
      <author>
        <name>Kolvenbach, Caroline M</name>
      </author>
      <author>
        <name>Shril, Shirlee</name>
      </author>
      <author>
        <name>Hildebrandt, Friedhelm</name>
      </author>
      <author>
        <name>Noureldeen, Mahmoud M</name>
      </author>
      <author>
        <name>Salem, Aida MS</name>
      </author>
      <author>
        <name>Takahashi, Yukitoshi</name>
      </author>
      <author>
        <name>Salimi-Dafsari, Hormos</name>
      </author>
      <author>
        <name>Phillips, H Westley</name>
      </author>
      <author>
        <name>Hanak, Brian</name>
      </author>
      <author>
        <name>Kara, Bülent</name>
      </author>
      <author>
        <name>Güneş, Ayfer Sakarya</name>
      </author>
      <author>
        <name>Gonda, David D</name>
      </author>
      <author>
        <name>Kirmani, Salman</name>
      </author>
      <author>
        <name>Tkemaladze, Tinatin</name>
      </author>
      <author>
        <name>Gleeson, Joseph G</name>
      </author>
    </item>
    <item>
      <title>Offering extended use of the contraceptive implant via an implementation science framework: a qualitative study of clinicians’ perceived barriers and facilitators</title>
      <link>https://escholarship.org/uc/item/3x38d94c</link>
      <description>BackgroundThe etonogestrel contraceptive implant is currently approved by the United States Food and Drug Administration (FDA) for the prevention of pregnancy up to 3 years. However, studies that suggest efficacy up to 5 years. There is little information on the prevalence of extended use and the factors that influence clinicians in offering extended use. We investigated clinician perspectives on the barriers and facilitators to offering extended use of the contraceptive implant.
MethodsUsing the Consolidated Framework for Implementation Research (CFIR), we conducted semi-structured qualitative interviews. Participants were recruited from a nationwide survey study of reproductive health clinicians on their knowledge and perspective of extended use of the contraceptive implant. To optimize the diversity of perspectives, we purposefully sampled participants from this study. We used content analysis and consensual qualitative research methods to inform our coding and data analysis....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3x38d94c</guid>
      <pubDate>Fri, 21 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Rigler, Nicole</name>
      </author>
      <author>
        <name>Kully, Gennifer</name>
      </author>
      <author>
        <name>Hildebrand, Marisa C</name>
        <uri>https://orcid.org/0000-0001-8882-9451</uri>
      </author>
      <author>
        <name>Averbach, Sarah</name>
      </author>
      <author>
        <name>Mody, Sheila K</name>
      </author>
    </item>
    <item>
      <title>Time from first clinical contact to abortion in Texas and California</title>
      <link>https://escholarship.org/uc/item/35q765dr</link>
      <description>OBJECTIVE: To assess whether having an abortion in Texas, a U.S. state with many restrictive abortion laws, is associated with increased time between contacting an abortion provider and receiving an abortion, compared to having an abortion in California, a less restrictive U.S. state.
STUDY DESIGN: This is a multisite, cross-sectional survey of 434 patients in 12 abortion facilities (ambulatory surgical centers and clinics) in Texas (n&amp;nbsp;=&amp;nbsp;291) and three abortion clinics in California (n&amp;nbsp;=&amp;nbsp;143) from 2018 to 2019. At 11 facilities in Texas the response rate was 76%. The response rate was not collected at other sites. We compare the clinical-contact-to-abortion time interval between the facilities in these two states using mixed-effects multivariable logistic regression, adjusting for age, race, education, household income, parity, marital status, and insurance status. We also compare barriers to scheduling and traveling to abortion appointments.
RESULTS: Median...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/35q765dr</guid>
      <pubDate>Tue, 18 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Adams, Madeline</name>
      </author>
      <author>
        <name>Kully, Gennifer</name>
      </author>
      <author>
        <name>Tilford, Sarah</name>
      </author>
      <author>
        <name>White, Kari</name>
      </author>
      <author>
        <name>Mody, Sheila</name>
        <uri>https://orcid.org/0000-0002-8705-7362</uri>
      </author>
      <author>
        <name>Hildebrand, Marisa</name>
        <uri>https://orcid.org/0000-0001-8882-9451</uri>
      </author>
      <author>
        <name>Johns, Nicole</name>
        <uri>https://orcid.org/0000-0003-4513-4582</uri>
      </author>
      <author>
        <name>Grossman, Daniel</name>
      </author>
      <author>
        <name>Averbach, Sarah</name>
      </author>
    </item>
    <item>
      <title>Norepinephrine Neurons in the Nucleus of the Solitary Tract Suppress Luteinizing Hormone Secretion in Female Mice</title>
      <link>https://escholarship.org/uc/item/1c30j3jt</link>
      <description>Stress impairs fertility, at least in part, via inhibition of gonadotropin secretion. Luteinizing hormone (LH) is an important gonadotropin that is released in a pulsatile pattern in males and in females throughout the majority of the ovarian cycle. Several models of stress, including acute metabolic stress, suppress LH pulses via inhibition of neurons in the arcuate nucleus of the hypothalamus that coexpress kisspeptin, neurokinin B, and dynorphin (termed KNDy cells) which form the pulse generator. The mechanism for inhibition of KNDy neurons during stress, however, remains a significant outstanding question. Here, we investigated a population of catecholamine neurons in the nucleus of the solitary tract (NTS), marked by expression of the enzyme dopamine beta-hydroxylase (DBH), in female mice. First, we found that a subpopulation of DBH neurons in the NTS is activated (express c-Fos) during metabolic stress. Then, using chemogenetics, we determined that activation of these cells...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1c30j3jt</guid>
      <pubDate>Sat, 1 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>McCosh, Richard B</name>
      </author>
      <author>
        <name>Kreisman, Michael J</name>
      </author>
      <author>
        <name>Tian, Katherine</name>
      </author>
      <author>
        <name>Thomas, Steven A</name>
      </author>
      <author>
        <name>Church, Kellie M Breen</name>
      </author>
    </item>
    <item>
      <title>Splicing does the two-step</title>
      <link>https://escholarship.org/uc/item/9bk8n5vg</link>
      <description>An intricate recursive RNA splicing mechanism that removes especially long introns (non-coding sequences) from genes has been found to be evolutionarily conserved and more prevalent than previously thought. See Letters p.371 &amp;amp; p.376</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9bk8n5vg</guid>
      <pubDate>Sat, 15 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cook-Andersen, Heidi</name>
        <uri>https://orcid.org/0000-0003-3916-5120</uri>
      </author>
      <author>
        <name>Wilkinson, Miles F</name>
      </author>
    </item>
    <item>
      <title>The RHOX Homeodomain Proteins Regulate the Expression of Insulin and Other Metabolic Regulators in the Testis*</title>
      <link>https://escholarship.org/uc/item/9424d4nz</link>
      <description>Defects in cellular metabolism have been widely implicated in causing male infertility, but there has been little progress in understanding the underlying mechanism. Here we report that several key metabolism genes are regulated in the testis by Rhox5, the founding member of a large X-linked homeobox gene cluster. Among these Rhox5-regulated genes are insulin 2 (Ins2), resistin (Retn), and adiponectin (Adipoq), all of which encode secreted proteins that have profound and wide-ranging effects on cellular metabolism. The ability of Rhox5 to regulate their levels in the testis has the potential to dictate metabolism locally in this organ, given the existence of the blood-testes barrier. We demonstrate that Ins2 is a direct target of Rhox5 in Sertoli cells, and we show that this regulation is physiologically significant, because Rhox5-null mice fail to up-regulate Ins2 expression during the first wave of spermatogenesis and have insulin-signaling defects. We identify other Rhox family...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9424d4nz</guid>
      <pubDate>Sat, 15 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>MacLean, James A</name>
      </author>
      <author>
        <name>Hu, Zhiying</name>
      </author>
      <author>
        <name>Welborn, Joshua P</name>
      </author>
      <author>
        <name>Song, Hye-Won</name>
      </author>
      <author>
        <name>Rao, Manjeet K</name>
      </author>
      <author>
        <name>Wayne, Chad M</name>
      </author>
      <author>
        <name>Wilkinson, Miles F</name>
      </author>
    </item>
    <item>
      <title>Posttranscriptional Control of the Stem Cell and Neurogenic Programs by the Nonsense-Mediated RNA Decay Pathway</title>
      <link>https://escholarship.org/uc/item/93z3f9zz</link>
      <description>The mechanisms dictating whether a cell proliferates or differentiates have undergone intense scrutiny, but they remain poorly understood. Here, we report that UPF1, a central component in the nonsense-mediated RNA decay (NMD) pathway, plays a key role in this decision by promoting the proliferative, undifferentiated cell state. UPF1 acts, in part, by destabilizing the NMD substrate encoding the TGF-β inhibitor SMAD7 and stimulating TGF-β signaling. UPF1 also promotes the decay of mRNAs encoding many other proteins that oppose the proliferative, undifferentiated cell state. Neural differentiation is triggered when NMD is downregulated by&amp;nbsp;neurally expressed microRNAs (miRNAs). This UPF1-miRNA circuitry is highly conserved and harbors negative feedback loops that act as a molecular switch. Our results suggest that the NMD pathway collaborates with the TGF-β signaling pathway to lock in the stem-like state, a cellular state that is stably reversed when neural differentiation...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/93z3f9zz</guid>
      <pubDate>Sat, 15 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Lou, Chih H</name>
      </author>
      <author>
        <name>Shao, Ada</name>
      </author>
      <author>
        <name>Shum, Eleen Y</name>
      </author>
      <author>
        <name>Espinoza, Josh L</name>
      </author>
      <author>
        <name>Huang, Lulu</name>
      </author>
      <author>
        <name>Karam, Rachid</name>
      </author>
      <author>
        <name>Wilkinson, Miles F</name>
      </author>
    </item>
    <item>
      <title>Epigenetic regulation of the RHOX homeobox gene cluster and its association with human male infertility</title>
      <link>https://escholarship.org/uc/item/55d7p3c9</link>
      <description>The X-linked RHOX cluster encodes a set of homeobox genes that are selectively expressed in the reproductive tract. Members of the RHOX cluster regulate target genes important for spermatogenesis promote male fertility in mice. Studies show that demethylating agents strongly upregulate the expression of mouse Rhox genes, suggesting that they are regulated by DNA methylation. However, whether this extends to human RHOX genes, whether DNA methylation directly regulates RHOX gene transcription and how this relates to human male infertility are unknown. To address these issues, we first defined the promoter regions of human RHOX genes and performed gain- and loss-of-function experiments to determine whether human RHOX gene transcription is regulated by DNA methylation. Our results indicated that DNA methylation is necessary and sufficient to silence human RHOX gene expression. To determine whether RHOX cluster methylation associates with male infertility, we evaluated the methylation...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/55d7p3c9</guid>
      <pubDate>Sat, 15 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Richardson, Marcy E</name>
      </author>
      <author>
        <name>Bleiziffer, Andreas</name>
      </author>
      <author>
        <name>Tüttelmann, Frank</name>
      </author>
      <author>
        <name>Gromoll, Jörg</name>
      </author>
      <author>
        <name>Wilkinson, Miles F</name>
      </author>
    </item>
    <item>
      <title>RNA degradation drives stem cell differentiation</title>
      <link>https://escholarship.org/uc/item/3c94744h</link>
      <description>The mechanisms by which multi‐potent stem cells switch their program to become functional differentiated cells have intrigued biologists for decades. Most focus has been on transcriptional pathways, but whether they have sufficient dynamic range to cause discrete shifts in cell state is not clear. Because the steady‐state level of RNAs is also dictated by their decay rate, an attractive possibility is that specific RNA decay mechanisms also have a role in promoting differentiation mechanisms. In this issue of The EMBO Journal, Li et&amp;nbsp;al (2015) obtained evidence that a highly conserved RNA degradation pathway called nonsense‐mediated RNA decay (NMD) is critical for the differentiation of embryonic stem (ES) cells.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3c94744h</guid>
      <pubDate>Sat, 15 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Lou, Chih‐Hong</name>
      </author>
      <author>
        <name>Shum, Eleen Y</name>
      </author>
      <author>
        <name>Wilkinson, Miles F</name>
      </author>
    </item>
    <item>
      <title>Hormone-induced and DNA Demethylation-induced Relief of a Tissue-specific and Developmentally Regulated Block in Transcriptional Elongation*</title>
      <link>https://escholarship.org/uc/item/264741x5</link>
      <description>Genome-wide studies have revealed that genes commonly have a high density of RNA polymerase II just downstream of the transcription start site. This has raised the possibility that genes are commonly regulated by transcriptional elongation, but this remains largely untested in vivo, particularly in vertebrates. Here, we show that the proximal promoter from the Rhox5 homeobox gene recruits polymerase II and begins elongating in all tissues and cell lines that we tested, but it only completes elongation in a tissue-specific and developmentally regulated manner. Relief of the elongation block is associated with recruitment of the elongation factor P-TEFb, the co-activator GRIP1, the chromatin remodeling factor BRG1, and specific histone modifications. We provide evidence that two mechanisms relieve the elongation block at the proximal promoter: demethylation and recruitment of androgen receptor. Together, our findings support a model in which promoter proximal pausing helps confer...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/264741x5</guid>
      <pubDate>Sat, 15 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Rao, Manjeet K</name>
      </author>
      <author>
        <name>Matsumoto, Yuiko</name>
      </author>
      <author>
        <name>Richardson, Marcy E</name>
      </author>
      <author>
        <name>Panneerdoss, Subbarayalu</name>
      </author>
      <author>
        <name>Bhardwaj, Anjana</name>
      </author>
      <author>
        <name>Ward, Jacqueline M</name>
      </author>
      <author>
        <name>Shanker, Sreenath</name>
      </author>
      <author>
        <name>Bettegowda, Anilkumar</name>
      </author>
      <author>
        <name>Wilkinson, Miles F</name>
      </author>
    </item>
    <item>
      <title>Nonsense-mediated mRNA decay: Inter-individual variability and human disease</title>
      <link>https://escholarship.org/uc/item/12b1f3t4</link>
      <description>Nonsense-mediated mRNA decay (NMD) is a regulatory pathway that functions to degrade transcripts containing premature termination codons (PTCs) and to maintain normal transcriptome homeostasis. Nonsense and frameshift mutations that generate PTCs cause approximately one-third of all known human genetic diseases and thus NMD has a potentially important role in human disease. In genetic disorders in which the affected genes carry PTC-generating mutations, NMD acts as a double-edge sword. While it can benefit the patient by degrading PTC-containing mRNAs that encode detrimental, dominant-negative truncated proteins, it can also make the disease worse when a PTC-containing mRNA is degraded that encodes a mutant but still functional protein. There is evidence that the magnitude of NMD varies between individuals, which, in turn, has been shown to correlate with both clinical presentations and the patients' responses to drugs that promote read-through of PTCs. In this review, we examine...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/12b1f3t4</guid>
      <pubDate>Sat, 15 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Nguyen, Lam Son</name>
      </author>
      <author>
        <name>Wilkinson, Miles F</name>
      </author>
      <author>
        <name>Gecz, Jozef</name>
      </author>
    </item>
    <item>
      <title>Transcriptional control of spermatogonial maintenance and differentiation</title>
      <link>https://escholarship.org/uc/item/0ck0039n</link>
      <description>Spermatogenesis is a multistep process that generates millions of spermatozoa per day in mammals. A key to this process is the spermatogonial stem cell (SSC), which has the dual property of continually renewing and undergoing differentiation into a spermatogonial progenitor that expands and further differentiates. In this review, we will focus on how these proliferative and early differentiation steps in mammalian male germ cells are controlled by transcription factors. Most of the transcription factors that have so far been identified as promoting SSC self-renewal (BCL6B, BRACHYURY, ETV5, ID4, LHX1, and POU3F1) are upregulated by glial cell line-derived neurotrophic factor (GDNF). Since GDNF is crucial for promoting SSC self-renewal, this suggests that these transcription factors are responsible for coordinating the action of GDNF in SSCs. Other transcription factors that promote SSC self-renewal are expressed independently of GDNF (FOXO1, PLZF, POU5F1, and TAF4B) and thus may...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0ck0039n</guid>
      <pubDate>Sat, 15 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Song, Hye-Won</name>
      </author>
      <author>
        <name>Wilkinson, Miles F</name>
      </author>
    </item>
    <item>
      <title>Discrimination Between Benign and Malignant Lesions With Restriction Spectrum Imaging MRI in an Enriched Breast Cancer Screening Cohort</title>
      <link>https://escholarship.org/uc/item/7kj446gv</link>
      <description>BACKGROUND: Breast cancer screening with dynamic contrast-enhanced MRI (DCE-MRI) is recommended for high-risk women but has limitations, including variable specificity and difficulty in distinguishing cancerous (CL) and high-risk benign lesions (HRBL) from average-risk benign lesions (ARBL). Complementary non-invasive imaging techniques would be useful to improve specificity.
PURPOSE: To evaluate the performance of a previously-developed breast-specific diffusion-weighted MRI (DW-MRI) model (BS-RSI3C) to improve discrimination between CL, HRBL, and ARBL in an enriched screening population.
STUDY TYPE: Prospective.
SUBJECTS: Exactly 187 women, either with mammography screening recommending additional imaging (N = 49) or high-risk individuals undergoing routine breast MRI (N = 138), before the biopsy.
FIELD STRENGTH/SEQUENCE: Multishell DW-MRI echo planar imaging sequence with a reduced field of view at 3.0 T.
ASSESSMENT: A total of 72 women had at least one biopsied lesion, with...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7kj446gv</guid>
      <pubDate>Fri, 14 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Loubrie, Stephane</name>
        <uri>https://orcid.org/0009-0009-0526-2281</uri>
      </author>
      <author>
        <name>Zou, Jingjing</name>
      </author>
      <author>
        <name>Rodriguez‐Soto, Ana E</name>
      </author>
      <author>
        <name>Lim, Jihe</name>
      </author>
      <author>
        <name>Andreassen, Maren MS</name>
      </author>
      <author>
        <name>Cheng, Yuwei</name>
      </author>
      <author>
        <name>Batasin, Summer J</name>
      </author>
      <author>
        <name>Ebrahimi, Sheida</name>
      </author>
      <author>
        <name>Fang, Lauren K</name>
      </author>
      <author>
        <name>Conlin, Christopher C</name>
        <uri>https://orcid.org/0000-0003-4509-8702</uri>
      </author>
      <author>
        <name>Seibert, Tyler M</name>
        <uri>https://orcid.org/0000-0002-4089-7399</uri>
      </author>
      <author>
        <name>Hahn, Michael E</name>
      </author>
      <author>
        <name>Dialani, Vandana</name>
      </author>
      <author>
        <name>Wei, Catherine J</name>
      </author>
      <author>
        <name>Karimi, Zahra</name>
      </author>
      <author>
        <name>Kuperman, Joshua</name>
      </author>
      <author>
        <name>Dale, Anders M</name>
      </author>
      <author>
        <name>Ojeda‐Fournier, Haydee</name>
      </author>
      <author>
        <name>Pisano, Etta</name>
      </author>
      <author>
        <name>Rakow‐Penner, Rebecca</name>
      </author>
    </item>
    <item>
      <title>Restriction Spectrum Imaging as a quantitative biomarker for prostate cancer with reliable positive predictive value</title>
      <link>https://escholarship.org/uc/item/3n7039sb</link>
      <description>Abstract  Background and Objective Positive predictive value of PI-RADS for clinically significant prostate cancer (csPCa, grade group [GG]≥2) varies widely between institutions and radiologists. The Restriction Spectrum Imaging restriction score (RSIrs) is a metric derived from diffusion MRI that could be an objectively interpretable biomarker for csPCa.   Methods In patients scanned for suspected or known csPCa at 7 centers, we calculated patient-level csPCa probability based on maximum RSIrs in the prostate, without relying on subjectively defined lesions. We used area under the ROC curve (AUC) to compare patient-level csPCa detection for RSIrs, ADC, and PI-RADS. Finally, we combined RSIrs with clinical risk factors via multivariable regression, training in a single-center cohort and testing in an independent, multi-center dataset.   Key Findings and Limitations  Among all patients (n=1892), probability of csPCa increased with higher RSIrs . GG≥4 csPCa was most common in patients...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3n7039sb</guid>
      <pubDate>Fri, 14 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Domingo, Mariluz Rojo</name>
      </author>
      <author>
        <name>D, Deondre</name>
      </author>
      <author>
        <name>Conlin, Christopher C</name>
      </author>
      <author>
        <name>Bagrodia, Aditya</name>
        <uri>https://orcid.org/0000-0002-3358-1193</uri>
      </author>
      <author>
        <name>Barrett, Tristan</name>
      </author>
      <author>
        <name>Baxter, Madison T</name>
      </author>
      <author>
        <name>Cooperberg, Matthew</name>
      </author>
      <author>
        <name>Feng, Felix</name>
      </author>
      <author>
        <name>Hahn, Michael E</name>
      </author>
      <author>
        <name>Harisinghani, Mukesh</name>
      </author>
      <author>
        <name>Hollenberg, Gary</name>
      </author>
      <author>
        <name>Javier-Desloges, Juan</name>
      </author>
      <author>
        <name>Kallis, Karoline</name>
      </author>
      <author>
        <name>Kamran, Sophia</name>
      </author>
      <author>
        <name>Kane, Christopher J</name>
      </author>
      <author>
        <name>Kessler, Dimitri</name>
      </author>
      <author>
        <name>Kuperman, Joshua</name>
      </author>
      <author>
        <name>Lee, Kang-Lung</name>
      </author>
      <author>
        <name>Levine, Jonathan</name>
      </author>
      <author>
        <name>Liss, Michael A</name>
      </author>
      <author>
        <name>Margolis, Daniel JA</name>
      </author>
      <author>
        <name>Matthews, Ian</name>
      </author>
      <author>
        <name>Murphy, Paul M</name>
      </author>
      <author>
        <name>Nakrour, Nabih</name>
      </author>
      <author>
        <name>Ohliger, Michael</name>
      </author>
      <author>
        <name>Ollison, Courtney</name>
      </author>
      <author>
        <name>Osinski, Thomas</name>
      </author>
      <author>
        <name>Pamatmat, Anthony James</name>
      </author>
      <author>
        <name>Pompa, Isabella R</name>
      </author>
      <author>
        <name>Rakow-Penner, Rebecca</name>
        <uri>https://orcid.org/0000-0002-2566-1978</uri>
      </author>
      <author>
        <name>Roberts, Jacob L</name>
        <uri>https://orcid.org/0009-0008-7746-7633</uri>
      </author>
      <author>
        <name>Santhosh, Karan</name>
      </author>
      <author>
        <name>Shabaik, Ahmed S</name>
      </author>
      <author>
        <name>Song, Yuze</name>
      </author>
      <author>
        <name>Song, David</name>
      </author>
      <author>
        <name>Tempany, Clare M</name>
      </author>
      <author>
        <name>Wehrli, Natasha</name>
      </author>
      <author>
        <name>Weinberg, Eric P</name>
      </author>
      <author>
        <name>Woolen, Sean</name>
      </author>
      <author>
        <name>Xu, George</name>
      </author>
      <author>
        <name>Zhong, Allison Y</name>
      </author>
      <author>
        <name>Dale, Anders M</name>
      </author>
      <author>
        <name>Seibert, Tyler M</name>
        <uri>https://orcid.org/0000-0002-4089-7399</uri>
      </author>
    </item>
    <item>
      <title>Robustness of a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancer: assessing for systematic bias due to age, race, ethnicity, prostate volume, medication use, or imaging acquisition parameters</title>
      <link>https://escholarship.org/uc/item/3480p381</link>
      <description>Introduction Prostate multiparametric magnetic resonance imaging (mpMRI) has greatly improved the detection of clinically significant prostate cancer (csPCa). However, the limited number of expert sub-specialist radiologists capable of interpreting conventional prostate mpMRI is a bottleneck for universal access to this healthcare advance. A reliable and reproducible quantitative imaging biomarker could facilitate implementation of accurate prostate MRI at clinical sites with limited experience, thus ensuring more equitable patient care. Restriction Spectrum Imaging restriction score (RSIrs) is an MRI biomarker that has shown the ability to enhance the qualitative and quantitative interpretation of prostate MRI. However, patient-level factors (age, race, ethnicity, prostate volume, and 5-alpha-reductase inhibitor (5-ARI) use) and acquisition-level factors (scanner manufacturer/model and protocol parameters) can affect prostate mpMRI, and their impact on quantitative RSIrs is unknown....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3480p381</guid>
      <pubDate>Fri, 14 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>D, Deondre</name>
      </author>
      <author>
        <name>Domingo, Mariluz Rojo</name>
      </author>
      <author>
        <name>Conlin, Christopher C</name>
      </author>
      <author>
        <name>Matthews, Ian</name>
      </author>
      <author>
        <name>Kallis, Karoline</name>
      </author>
      <author>
        <name>Baxter, Madison T</name>
      </author>
      <author>
        <name>Ollison, Courtney</name>
      </author>
      <author>
        <name>Song, Yuze</name>
      </author>
      <author>
        <name>Xu, George</name>
      </author>
      <author>
        <name>Zhong, Allison Y</name>
      </author>
      <author>
        <name>Bagrodia, Aditya</name>
        <uri>https://orcid.org/0000-0002-3358-1193</uri>
      </author>
      <author>
        <name>Barrett, Tristan</name>
      </author>
      <author>
        <name>Cooperberg, Matthew</name>
      </author>
      <author>
        <name>Feng, Felix</name>
      </author>
      <author>
        <name>Hahn, Michael E</name>
      </author>
      <author>
        <name>Harisinghani, Mukesh</name>
      </author>
      <author>
        <name>Hollenberg, Gary</name>
      </author>
      <author>
        <name>Javier-Desloges, Juan</name>
      </author>
      <author>
        <name>Kamran, Sophia C</name>
      </author>
      <author>
        <name>Kane, Christopher J</name>
      </author>
      <author>
        <name>Kessler, Dimitri</name>
      </author>
      <author>
        <name>Kuperman, Joshua</name>
      </author>
      <author>
        <name>Lee, Kang-Lung</name>
      </author>
      <author>
        <name>Levine, Jonathan</name>
      </author>
      <author>
        <name>Liss, Michael A</name>
      </author>
      <author>
        <name>Margolis, Daniel JA</name>
      </author>
      <author>
        <name>Murphy, Paul M</name>
      </author>
      <author>
        <name>Nakrour, Nabih</name>
      </author>
      <author>
        <name>Ohliger, Michael A</name>
      </author>
      <author>
        <name>Osinski, Thomas</name>
      </author>
      <author>
        <name>Pamatmat, Anthony James</name>
      </author>
      <author>
        <name>Pompa, Isabella R</name>
      </author>
      <author>
        <name>Rakow-Penner, Rebecca</name>
        <uri>https://orcid.org/0000-0002-2566-1978</uri>
      </author>
      <author>
        <name>Roberts, Jacob L</name>
        <uri>https://orcid.org/0009-0008-7746-7633</uri>
      </author>
      <author>
        <name>Santhosh, Karan</name>
      </author>
      <author>
        <name>Shabaik, Ahmed S</name>
        <uri>https://orcid.org/0000-0003-1987-3453</uri>
      </author>
      <author>
        <name>Song, David</name>
      </author>
      <author>
        <name>Tempany, Clare M</name>
      </author>
      <author>
        <name>Trecarten, Shaun</name>
      </author>
      <author>
        <name>Wehrli, Natasha</name>
      </author>
      <author>
        <name>Weinberg, Eric P</name>
      </author>
      <author>
        <name>Woolen, Sean</name>
      </author>
      <author>
        <name>Dale, Anders M</name>
      </author>
      <author>
        <name>Seibert, Tyler M</name>
      </author>
    </item>
    <item>
      <title>Longitudinal registration of T1-weighted breast MRI: A registration algorithm (FLIRE) and clinical application</title>
      <link>https://escholarship.org/uc/item/7mg2r6qb</link>
      <description>PURPOSE: MRI is commonly used to aid breast cancer diagnosis and treatment evaluation. For patients with breast cancer, neoadjuvant chemotherapy aims to reduce the tumor size and extent of surgery necessary. The current clinical standard to measure breast tumor response on MRI uses the longest tumor diameter. Radiologists also account for other tissue properties including tumor contrast or pharmacokinetics in their assessment. Accurate longitudinal image registration of breast tissue is critical to properly compare response to treatment at different timepoints.
METHODS: In this study, a deformable Fast Longitudinal Image Registration (FLIRE) algorithm was optimized for breast tissue. FLIRE was then compared to the publicly available software packages with high accuracy (DRAMMS) and fast runtime (Elastix). Patients included in the study received longitudinal T&lt;sub&gt;1&lt;/sub&gt;&lt;sub&gt;-&lt;/sub&gt;weighted MRI without fat saturation at two to six timepoints as part of asymptomatic screening (n&amp;nbsp;=&amp;nbsp;27)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7mg2r6qb</guid>
      <pubDate>Thu, 13 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Tong, Michelle W</name>
      </author>
      <author>
        <name>Yu, Hon J</name>
      </author>
      <author>
        <name>Sjaastad Andreassen, Maren M</name>
      </author>
      <author>
        <name>Loubrie, Stephane</name>
        <uri>https://orcid.org/0009-0009-0526-2281</uri>
      </author>
      <author>
        <name>Rodríguez-Soto, Ana E</name>
      </author>
      <author>
        <name>Seibert, Tyler M</name>
      </author>
      <author>
        <name>Rakow-Penner, Rebecca</name>
        <uri>https://orcid.org/0000-0002-2566-1978</uri>
      </author>
      <author>
        <name>Dale, Anders M</name>
      </author>
    </item>
    <item>
      <title>Barriers and facilitators to telemedicine contraception among patients that speak Spanish: a qualitative study</title>
      <link>https://escholarship.org/uc/item/57b8x77r</link>
      <description>Background: Telemedicine contraception services have increased since the COVID-19 pandemic. There may be unique equity implications and language barriers for patients who speak Spanish.
Objective: To identify the barriers and facilitators of telemedicine for contraception care among patients who speak Spanish using a community-based participatory research approach.
Study Design: The study was designed and conducted in consultation with a community advisory board. We interviewed 20 patients after telemedicine and in-person contraception visits conducted in Spanish at Planned Parenthood of the Pacific Southwest in Southern California between April 2022 and May 2023. Telemedicine visits were conducted by audio only. Two coders analyzed the data using thematic analysis.
Results: The average age of the participants was 32.5 years old (range 19-45). Most participants had some college education (13/20, 65.0%) and public insurance (18/20, 90.0%). Most chose a short-acting contraceptive...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/57b8x77r</guid>
      <pubDate>Thu, 13 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Meurice, Marielle E</name>
      </author>
      <author>
        <name>Kully, Gennifer</name>
      </author>
      <author>
        <name>Averbach, Sarah</name>
      </author>
      <author>
        <name>Marengo, Antoinette</name>
      </author>
      <author>
        <name>Nodora, Jesse</name>
      </author>
      <author>
        <name>Cervantes, Maricela</name>
      </author>
      <author>
        <name>Mody, Sheila K</name>
        <uri>https://orcid.org/0000-0002-8705-7362</uri>
      </author>
    </item>
    <item>
      <title>Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost</title>
      <link>https://escholarship.org/uc/item/4j2051jc</link>
      <description>PURPOSE: The focal radiation therapy (RT) boost technique was shown in a phase III randomized controlled trial (RCT) to improve prostate cancer outcomes without increasing toxicity. This technique relies on the accurate delineation of prostate tumors on MRI. A recent prospective study evaluated radiation oncologists' accuracy when asked to delineate prostate tumors on MRI and demonstrated high variability in tumor contours. We sought to evaluate the impact of contour variability and inaccuracy on predicted clinical outcomes. We hypothesized that radiation oncologists' contour inaccuracies would yield meaningfully worse clinical outcomes.
METHODS AND MATERIALS: Forty-five radiation oncologists and 2 expert radiologists contoured prostate tumors on 30 patient cases. Of these cases, those with CT simulation or diagnostic CT available were selected for analysis. A knowledge-based planning model was developed to generate focal RT boost plans for each contour per the RCT protocol. The...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4j2051jc</guid>
      <pubDate>Thu, 13 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Zhong, Allison Y</name>
      </author>
      <author>
        <name>Lui, Asona J</name>
        <uri>https://orcid.org/0000-0002-0076-3492</uri>
      </author>
      <author>
        <name>Kuznetsova, Svetlana</name>
      </author>
      <author>
        <name>Kallis, Karoline</name>
      </author>
      <author>
        <name>Conlin, Christopher</name>
        <uri>https://orcid.org/0000-0003-4509-8702</uri>
      </author>
      <author>
        <name>Do, Deondre D</name>
      </author>
      <author>
        <name>Domingo, Mariluz Rojo</name>
      </author>
      <author>
        <name>Manger, Ryan</name>
      </author>
      <author>
        <name>Hua, Patricia</name>
      </author>
      <author>
        <name>Karunamuni, Roshan</name>
      </author>
      <author>
        <name>Kuperman, Joshua</name>
      </author>
      <author>
        <name>Dale, Anders M</name>
      </author>
      <author>
        <name>Rakow-Penner, Rebecca</name>
        <uri>https://orcid.org/0000-0002-2566-1978</uri>
      </author>
      <author>
        <name>Hahn, Michael E</name>
      </author>
      <author>
        <name>van der Heide, Uulke A</name>
      </author>
      <author>
        <name>Ray, Xenia</name>
      </author>
      <author>
        <name>Seibert, Tyler M</name>
        <uri>https://orcid.org/0000-0002-4089-7399</uri>
      </author>
    </item>
    <item>
      <title>Deep learning AI and Restriction Spectrum Imaging for patient-level detection of clinically significant prostate cancer on MRI</title>
      <link>https://escholarship.org/uc/item/1jt2g256</link>
      <description>Abstract  Background The Prostate Imaging Reporting &amp;amp; Data System (PI-RADS), based on multiparametric MRI (mpMRI), is widely used for the detection of clinically significant prostate cancer (csPCa, Gleason Grade Group (GG≥2)). However, its diagnostic accuracy can be impacted by variability in interpretation. Restriction Spectrum Imaging (RSI), an advanced diffusion-weighted technique, offers a standardized, quantitative approach for detecting csPCa, potentially enhancing diagnostic consistency and performing comparably to expert-level assessments.   Purpose To evaluate whether combining maximum RSI-derived restriction scores (RSIrs-max) with deep learning (DL) models can enhance patient-level detection of csPCa compared to using PI-RADS or RSIrs-max alone.   Materials and Methods Data from 1,892 patients across seven institutions were analyzed, selected based on MRI results and biopsy-confirmed diagnoses. Two deep learning architectures, 3D-DenseNet and 3D-DenseNet+RSI (incorporating...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1jt2g256</guid>
      <pubDate>Thu, 13 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Song, Yuze</name>
      </author>
      <author>
        <name>Domingo, Mariluz Rojo</name>
      </author>
      <author>
        <name>Conlin, Christopher C</name>
        <uri>https://orcid.org/0000-0003-4509-8702</uri>
      </author>
      <author>
        <name>D, Deondre</name>
      </author>
      <author>
        <name>Baxter, Madison T</name>
      </author>
      <author>
        <name>Dornisch, Anna</name>
      </author>
      <author>
        <name>Xu, George</name>
      </author>
      <author>
        <name>Bagrodia, Aditya</name>
        <uri>https://orcid.org/0000-0002-3358-1193</uri>
      </author>
      <author>
        <name>Barrett, Tristan</name>
      </author>
      <author>
        <name>Harisinghani, Mukesh</name>
      </author>
      <author>
        <name>Hollenberg, Gary</name>
      </author>
      <author>
        <name>Kamran, Sophia</name>
      </author>
      <author>
        <name>Kane, Christopher J</name>
      </author>
      <author>
        <name>Kessler, Dimitri A</name>
      </author>
      <author>
        <name>Kuperman, Joshua</name>
      </author>
      <author>
        <name>Lee, Kanglung</name>
      </author>
      <author>
        <name>Liss, Michael A</name>
      </author>
      <author>
        <name>Margolis, Daniel JA</name>
      </author>
      <author>
        <name>Murphy, Paul M</name>
      </author>
      <author>
        <name>Nakrour, Nabih</name>
      </author>
      <author>
        <name>Ngyuen, Truong</name>
      </author>
      <author>
        <name>Osinski, Thomas L</name>
      </author>
      <author>
        <name>Rakow-penner, Rebecca</name>
        <uri>https://orcid.org/0000-0002-2566-1978</uri>
      </author>
      <author>
        <name>Roychowdhury, Shoumik</name>
      </author>
      <author>
        <name>Shabik, Ahmed S</name>
      </author>
      <author>
        <name>Trecarten, Shaun</name>
      </author>
      <author>
        <name>Wehrli, Natasha</name>
      </author>
      <author>
        <name>Weinberg, Eric P</name>
      </author>
      <author>
        <name>Woolen, Sean A</name>
      </author>
      <author>
        <name>Dale, Anders M</name>
      </author>
      <author>
        <name>Seibert, Tyler M</name>
      </author>
    </item>
    <item>
      <title>Selective depletion of kisspeptin neurons in the hypothalamic arcuate nucleus in early juvenile life reduces pubertal LH secretion and delays puberty onset in mice</title>
      <link>https://escholarship.org/uc/item/2cw418qz</link>
      <description>Puberty is the critical developmental transition to reproductive capability driven by the activation of gonadotropin-releasing hormone (GnRH) neurons. The complex neural mechanisms underlying pubertal activation of GnRH secretion still remain unknown, yet likely include kisspeptin neurons. However, kisspeptin neurons reside in several hypothalamic areas and the specific kisspeptin population timing pubertal onset remains undetermined. To investigate this, we strategically capitalized on the differential ontological expression of the Kiss1 gene in different hypothalamic nuclei to selectively ablate just arcuate kisspeptin neurons (aka KNDy neurons) during the early juvenile period, well before puberty, while sparing RP3V kisspeptin neurons. Both male and female transgenic mice with a majority of their KNDy neurons ablated (KNDy&lt;sup&gt;ABL&lt;/sup&gt;) by diphtheria toxin treatment in juvenile life demonstrated significantly delayed puberty onset and lower peripubertal LH secretion than...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2cw418qz</guid>
      <pubDate>Wed, 12 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Coutinho, Eulalia A</name>
      </author>
      <author>
        <name>Esparza, Lourdes A</name>
      </author>
      <author>
        <name>Steffen, Paige H</name>
      </author>
      <author>
        <name>Liaw, Reanna</name>
      </author>
      <author>
        <name>Bolleddu, Shreyana</name>
      </author>
      <author>
        <name>Kauffman, Alexander S</name>
      </author>
    </item>
    <item>
      <title>Androgen Inhibition of Reproductive Neuroendocrine Function in Females and Transgender Males</title>
      <link>https://escholarship.org/uc/item/0mp9d1d9</link>
      <description>Ovarian function is controlled by pituitary secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH), which in turn are governed by gonadotropin releasing hormone (GnRH) secreted from the brain. A fundamental principle of reproductive axis regulation is negative feedback signaling by gonadal sex steroids back to the brain to fine-tune GnRH and gonadotropin secretion. Endogenous negative feedback effects can be mimicked by exogenous steroid treatments, including androgens, in both sexes. Indeed, a growing number of clinical and animal studies indicate that high levels of exogenous androgens, in the typically male physiological range, can inhibit LH secretion in females, as occurs in males. However, the mechanisms by which male-level androgens inhibit GnRH and LH secretion still remain poorly understood, and this knowledge gap is particularly pronounced in transgender men (individuals designated female at birth but identifying as male). Indeed, many transgender...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0mp9d1d9</guid>
      <pubDate>Wed, 12 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Kauffman, Alexander S</name>
      </author>
    </item>
    <item>
      <title>Immediate skin‐to‐skin contact and postpartum hemorrhagic morbidity</title>
      <link>https://escholarship.org/uc/item/5jc321c3</link>
      <description>OBJECTIVE: To examine rates of postpartum hemorrhagic (PPH) morbidity among patients who did and did not have immediate skin-to-skin contact (SSC).
METHODS: This study was a retrospective cohort of all non-anomalous, term singleton vaginal births at a Level IV center over 2 years. Exclusion criteria included COVID-19. Immediate SSC was defined as at least 60 min of direct contact initiated between parturient and neonate within 10 min of birth. The primary outcome was a composite of maternal morbidity related to PPH compared among those with and without immediate SSC. We used multivariable Poisson regression adjusted for possible confounders with robust error variance to determine the strength of the association.
RESULTS: Of 8623 deliveries during the study period, 3520 (40.8%) deliveries were included; of which 2428 (55.5%) had immediate SSC and 1028 (31.0%) did not. Immediate SSC reduced the overall rate of composite morbidity (adjusted relative risk 0.78, 95% confidence interval...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5jc321c3</guid>
      <pubDate>Thu, 30 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Wiley, Rachel L</name>
        <uri>https://orcid.org/0000-0003-2158-4482</uri>
      </author>
      <author>
        <name>Ghose, Ipsita</name>
      </author>
      <author>
        <name>Canfield, Dana R</name>
      </author>
      <author>
        <name>Sarker, Minhazur R</name>
      </author>
      <author>
        <name>Mendez‐Figueroa, Hector</name>
      </author>
      <author>
        <name>Chauhan, Suneet</name>
      </author>
    </item>
    <item>
      <title>Genomic surveillance reveals dynamic shifts in the connectivity of COVID-19 epidemics</title>
      <link>https://escholarship.org/uc/item/2bc8z2t0</link>
      <description>The maturation of genomic surveillance in the past decade has enabled tracking of the emergence and spread of epidemics at an unprecedented level. During the COVID-19 pandemic, for example, genomic data revealed that local epidemics varied considerably in the frequency of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage importation and persistence, likely due to a combination of COVID-19 restrictions and changing connectivity. Here, we show that local COVID-19 epidemics are driven by regional transmission, including across international boundaries, but can become increasingly connected to distant locations following the relaxation of public health interventions. By integrating genomic, mobility, and epidemiological data, we find abundant transmission occurring between both adjacent and distant locations, supported by dynamic mobility patterns. We find that changing connectivity significantly influences local COVID-19 incidence. Our findings demonstrate a complex...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2bc8z2t0</guid>
      <pubDate>Sat, 4 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Matteson, Nathaniel L</name>
      </author>
      <author>
        <name>Hassler, Gabriel W</name>
      </author>
      <author>
        <name>Kurzban, Ezra</name>
      </author>
      <author>
        <name>Schwab, Madison A</name>
      </author>
      <author>
        <name>Perkins, Sarah A</name>
      </author>
      <author>
        <name>Gangavarapu, Karthik</name>
      </author>
      <author>
        <name>Levy, Joshua I</name>
      </author>
      <author>
        <name>Parker, Edyth</name>
      </author>
      <author>
        <name>Pride, David</name>
      </author>
      <author>
        <name>Hakim, Abbas</name>
      </author>
      <author>
        <name>De Hoff, Peter</name>
      </author>
      <author>
        <name>Cheung, Willi</name>
      </author>
      <author>
        <name>Castro-Martinez, Anelizze</name>
      </author>
      <author>
        <name>Rivera, Andrea</name>
      </author>
      <author>
        <name>Veder, Anthony</name>
        <uri>https://orcid.org/0009-0000-6708-9538</uri>
      </author>
      <author>
        <name>Rivera, Ariana</name>
        <uri>https://orcid.org/0009-0001-8732-8863</uri>
      </author>
      <author>
        <name>Wauer, Cassandra</name>
      </author>
      <author>
        <name>Holmes, Jacqueline</name>
      </author>
      <author>
        <name>Wilson, Jedediah</name>
      </author>
      <author>
        <name>Ngo, Shayla N</name>
      </author>
      <author>
        <name>Plascencia, Ashley</name>
      </author>
      <author>
        <name>Lawrence, Elijah S</name>
      </author>
      <author>
        <name>Smoot, Elizabeth W</name>
      </author>
      <author>
        <name>Eisner, Emily R</name>
      </author>
      <author>
        <name>Tsai, Rebecca</name>
      </author>
      <author>
        <name>Chacón, Marisol</name>
      </author>
      <author>
        <name>Baer, Nathan A</name>
      </author>
      <author>
        <name>Seaver, Phoebe</name>
      </author>
      <author>
        <name>Salido, Rodolfo A</name>
      </author>
      <author>
        <name>Aigner, Stefan</name>
        <uri>https://orcid.org/0000-0002-9511-3328</uri>
      </author>
      <author>
        <name>Ngo, Toan T</name>
      </author>
      <author>
        <name>Barber, Tom</name>
      </author>
      <author>
        <name>Ostrander, Tyler</name>
      </author>
      <author>
        <name>Fielding-Miller, Rebecca</name>
        <uri>https://orcid.org/0000-0002-5099-0589</uri>
      </author>
      <author>
        <name>Simmons, Elizabeth H</name>
        <uri>https://orcid.org/0000-0002-0646-3458</uri>
      </author>
      <author>
        <name>Zazueta, Oscar E</name>
      </author>
      <author>
        <name>Serafin-Higuera, Idanya</name>
      </author>
      <author>
        <name>Sanchez-Alavez, Manuel</name>
      </author>
      <author>
        <name>Moreno-Camacho, Jose L</name>
      </author>
      <author>
        <name>García-Gil, Abraham</name>
      </author>
      <author>
        <name>Murphy Schafer, Ashleigh R</name>
      </author>
      <author>
        <name>McDonald, Eric</name>
      </author>
      <author>
        <name>Corrigan, Jeremy</name>
      </author>
      <author>
        <name>Malone, John D</name>
      </author>
      <author>
        <name>Stous, Sarah</name>
      </author>
      <author>
        <name>Shah, Seema</name>
      </author>
      <author>
        <name>Moshiri, Niema</name>
        <uri>https://orcid.org/0000-0003-2209-8128</uri>
      </author>
      <author>
        <name>Weiss, Alana</name>
      </author>
      <author>
        <name>Anderson, Catelyn</name>
      </author>
      <author>
        <name>Aceves, Christine M</name>
      </author>
      <author>
        <name>Spencer, Emily G</name>
      </author>
      <author>
        <name>Hufbauer, Emory C</name>
      </author>
      <author>
        <name>Lee, Justin J</name>
      </author>
      <author>
        <name>King, Alison J</name>
      </author>
      <author>
        <name>Ramesh, Karthik S</name>
      </author>
      <author>
        <name>Nguyen, Kelly N</name>
      </author>
      <author>
        <name>Saucedo, Kieran</name>
      </author>
      <author>
        <name>Robles-Sikisaka, Refugio</name>
      </author>
      <author>
        <name>Fisch, Kathleen M</name>
        <uri>https://orcid.org/0000-0002-0117-7444</uri>
      </author>
      <author>
        <name>Gonias, Steven L</name>
      </author>
      <author>
        <name>Birmingham, Amanda</name>
        <uri>https://orcid.org/0000-0002-4117-3317</uri>
      </author>
      <author>
        <name>McDonald, Daniel</name>
      </author>
      <author>
        <name>Karthikeyan, Smruthi</name>
      </author>
      <author>
        <name>Martin, Natasha K</name>
      </author>
      <author>
        <name>Schooley, Robert T</name>
      </author>
      <author>
        <name>Negrete, Agustin J</name>
      </author>
      <author>
        <name>Reyna, Horacio J</name>
      </author>
      <author>
        <name>Chavez, Jose R</name>
      </author>
      <author>
        <name>Garcia, Maria L</name>
      </author>
      <author>
        <name>Cornejo-Bravo, Jose M</name>
      </author>
      <author>
        <name>Becker, David</name>
      </author>
      <author>
        <name>Isaksson, Magnus</name>
      </author>
      <author>
        <name>Washington, Nicole L</name>
      </author>
      <author>
        <name>Lee, William</name>
      </author>
      <author>
        <name>Garfein, Richard S</name>
        <uri>https://orcid.org/0000-0003-3663-7153</uri>
      </author>
      <author>
        <name>Luna-Ruiz Esparza, Marco A</name>
      </author>
      <author>
        <name>Alcántar-Fernández, Jonathan</name>
      </author>
      <author>
        <name>Henson, Benjamin</name>
      </author>
      <author>
        <name>Jepsen, Kristen</name>
      </author>
      <author>
        <name>Olivares-Flores, Beatriz</name>
      </author>
      <author>
        <name>Barrera-Badillo, Gisela</name>
      </author>
      <author>
        <name>Lopez-Martínez, Irma</name>
      </author>
      <author>
        <name>Ramírez-González, José E</name>
      </author>
      <author>
        <name>Flores-León, Rita</name>
      </author>
      <author>
        <name>Kingsmore, Stephen F</name>
      </author>
      <author>
        <name>Sanders, Alison</name>
      </author>
      <author>
        <name>Pradenas, Allorah</name>
      </author>
      <author>
        <name>White, Benjamin</name>
      </author>
      <author>
        <name>Matthews, Gary</name>
      </author>
      <author>
        <name>Hale, Matt</name>
      </author>
      <author>
        <name>McLawhon, Ronald W</name>
      </author>
      <author>
        <name>Reed, Sharon L</name>
      </author>
      <author>
        <name>Winbush, Terri</name>
      </author>
      <author>
        <name>McHardy, Ian H</name>
      </author>
      <author>
        <name>Fielding, Russel A</name>
      </author>
      <author>
        <name>Nicholson, Laura</name>
      </author>
      <author>
        <name>Quigley, Michael M</name>
      </author>
      <author>
        <name>Harding, Aaron</name>
      </author>
      <author>
        <name>Mendoza, Art</name>
      </author>
      <author>
        <name>Bakhtar, Omid</name>
      </author>
    </item>
    <item>
      <title>Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma</title>
      <link>https://escholarship.org/uc/item/1z95c9nn</link>
      <description>ABSTRACT: Tumor chemotherapy resistance arises frequently and limits high-grade serous ovarian cancer (HGSOC) patient survival. Focal adhesion kinase (FAK) is an intracellular protein–tyrosine kinase encoded by PTK2, a gene that is often gained in HGSOC. Canonically, FAK functions at the cell periphery. However, FAK also transits to the nucleus to modulate gene expression. We find that FAK is tyrosine-phosphorylated and nuclear-localized in tumors of patients with HGSOC surviving neoadjuvant platinum–paclitaxel chemotherapy and that FAK nuclear accumulation occurs upon subcytotoxic cisplatin exposure to ovarian tumor cells in vitro. FAK nuclear localization sequence (NLS) mutational inactivation resulted in tumor cell sensitization to cisplatin in vitro and in vivo relative to wild-type FAK-reconstituted ovarian tumor cells. Cisplatin cytotoxicity was associated with elevated ERK MAPK activation in FAK NLS− cells, cisplatin-stimulated ERK activation was also enhanced upon loss...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1z95c9nn</guid>
      <pubDate>Sat, 28 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Zhang, Yichi</name>
      </author>
      <author>
        <name>Ojalill, Marjaana</name>
      </author>
      <author>
        <name>Boyer, Antonia</name>
        <uri>https://orcid.org/0009-0008-2716-8280</uri>
      </author>
      <author>
        <name>Chen, Xiao Lei</name>
        <uri>https://orcid.org/0000-0001-7998-9963</uri>
      </author>
      <author>
        <name>Tahon, Elise</name>
      </author>
      <author>
        <name>Lioux, Gaëtan Thivolle</name>
      </author>
      <author>
        <name>Xia, Marvin</name>
      </author>
      <author>
        <name>Abbas, Maryam</name>
      </author>
      <author>
        <name>Soylu, Halime Meryem</name>
      </author>
      <author>
        <name>Flieder, Douglas B</name>
      </author>
      <author>
        <name>Connolly, Denise C</name>
      </author>
      <author>
        <name>Molinolo, Alfredo A</name>
      </author>
      <author>
        <name>McHale, Michael T</name>
      </author>
      <author>
        <name>Stupack, Dwayne G</name>
      </author>
      <author>
        <name>Schlaepfer, David D</name>
        <uri>https://orcid.org/0000-0003-4814-9210</uri>
      </author>
    </item>
    <item>
      <title>Quantitative MRI biomarker for classification of clinically significant prostate cancer: Calibration for reproducibility across echo times</title>
      <link>https://escholarship.org/uc/item/0q88v8zf</link>
      <description>PURPOSE: The purpose of the present study is to develop a calibration method to account for differences in echo times (TE) and facilitate the use of restriction spectrum imaging restriction score (RSIrs) as a quantitative biomarker for the detection of clinically significant prostate cancer (csPCa).
METHODS: This study included 197 consecutive patients who underwent MRI and biopsy examination; 97 were diagnosed with csPCa (grade group ≥ 2). RSI data were acquired three times during the same session: twice at minimum TE ~75&amp;nbsp;ms and once at TE&amp;nbsp;=&amp;nbsp;90&amp;nbsp;ms (TEmin&lt;sub&gt;1&lt;/sub&gt;, TEmin&lt;sub&gt;2&lt;/sub&gt;, and TE90, respectively). A linear regression model was determined to match the C-maps of TE90 to the reference C-maps of TEmin&lt;sub&gt;1&lt;/sub&gt; within the interval ranging from 95th to 99th percentile of signal intensity within the prostate. RSIrs comparisons were made at the 98th percentile within each patient's prostate. We compared RSIrs from calibrated TE90 (RSIrs&lt;sub&gt;TE90corr&lt;/sub&gt;)...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0q88v8zf</guid>
      <pubDate>Sat, 28 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Kallis, Karoline</name>
      </author>
      <author>
        <name>Conlin, Christopher C</name>
        <uri>https://orcid.org/0000-0003-4509-8702</uri>
      </author>
      <author>
        <name>Ollison, Courtney</name>
      </author>
      <author>
        <name>Hahn, Michael E</name>
      </author>
      <author>
        <name>Rakow‐Penner, Rebecca</name>
      </author>
      <author>
        <name>Dale, Anders M</name>
      </author>
      <author>
        <name>Seibert, Tyler M</name>
      </author>
    </item>
    <item>
      <title>Durable antitumor response via an oncolytic virus encoding decoy-resistant IL-18</title>
      <link>https://escholarship.org/uc/item/3qs1h38m</link>
      <description>BACKGROUND: Interleukin-18 (IL-18), or interferon (IFN)-γ-inducing factor, potentiates T helper 1 and natural killer cell activation as well as CD8&lt;sup&gt;+&lt;/sup&gt; T-cell proliferation. Recombinant IL-18 has displayed limited clinical efficacy in part due to the expression of the decoy receptor, IL-18 binding protein (IL-18BP). A series of IL-18 variants that are devoid of IL-18BP binding, termed DR18 (decoy-resistant IL-18), was developed via directed evolution. We tested DR18 using oncolytic adenovirus (oAd) as a platform for delivery in syngeneic mouse tumor models.
METHODS: oAd harboring wild-type IL-18 or DR18 (oAdDR18) was constructed by inserting IL-18 mutant into modified oAd backbone with Ad5/3 chimeric fiber. The delivery effect and IFN-γ induction were determined by ELISA. The antitumor efficiency of oAdDR18 was tested in CT26, B16BL6 and 4T1 tumor-bearing mice, or athymic nude mice and compared with recombinant DR18 protein (rDR18). 4T1 lung metastasis model was used to...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3qs1h38m</guid>
      <pubDate>Tue, 24 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Cheng, Yan</name>
      </author>
      <author>
        <name>Zhao, Yuanhui</name>
      </author>
      <author>
        <name>Liu, Yu</name>
      </author>
      <author>
        <name>Zhang, Yichi</name>
      </author>
      <author>
        <name>Xu, Dongge</name>
      </author>
      <author>
        <name>Sun, Weikang</name>
      </author>
      <author>
        <name>Zhang, Mengyu</name>
      </author>
      <author>
        <name>Miao, Yuqing</name>
      </author>
      <author>
        <name>He, Susu</name>
      </author>
      <author>
        <name>Hou, Yayi</name>
      </author>
      <author>
        <name>Stupack, Dwayne</name>
      </author>
      <author>
        <name>Li, Erguang</name>
      </author>
    </item>
    <item>
      <title>Community utilization of a co-created COVID-19 testing program in a US/Mexico border community</title>
      <link>https://escholarship.org/uc/item/95r7m7gj</link>
      <description>BackgroundThe COVID-19 pandemic exposed several health disparities experienced by underserved and Latino/a communities, including inequitable access to COVID-19 testing.Objective and GoalsTo describe the utilization of a community-driven and culturally-tailored testing model on COVID-19 testing in an underserved Latino/a community in San Diego.MethodsThe Community-driven Optimization of COVID-19 testing to Reach and Engage Underserved Areas for Testing Equity (CO-CREATE) project implemented a community co-designed COVID-19 testing program in partnership with a Federally Qualified Health Center in a US/Mexico border community.ResultsBetween May 2021 and March 2023, 24, 422 COVID-19 PCR tests were administered to 13,253 individuals, among whom 93% percent identified as Latino/a, 57% spoke Spanish in the home, and 38% resided in our target community adjacent to the US/Mexico border, San Ysidro. Based on a subset of available county testing data, CO-CREATE accounted for nearly 12%...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/95r7m7gj</guid>
      <pubDate>Mon, 16 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Reyes, Breanna J</name>
      </author>
      <author>
        <name>Calvillo, Stephenie Tinoco</name>
      </author>
      <author>
        <name>Escoto, Arleth A</name>
      </author>
      <author>
        <name>Lomeli, Angel</name>
      </author>
      <author>
        <name>Burola, Maria Linda</name>
      </author>
      <author>
        <name>Gay, Luis</name>
      </author>
      <author>
        <name>Cohen, Ariel</name>
      </author>
      <author>
        <name>Villegas, Isabel</name>
      </author>
      <author>
        <name>Salgin, Linda</name>
      </author>
      <author>
        <name>Cain, Kelli L</name>
      </author>
      <author>
        <name>Pilz, Dylan</name>
      </author>
      <author>
        <name>Watson, Paul</name>
      </author>
      <author>
        <name>Oswald, Bill</name>
      </author>
      <author>
        <name>Arevalo, Cesar</name>
      </author>
      <author>
        <name>Sanchez, Jessica</name>
      </author>
      <author>
        <name>Richardson, Marjorie</name>
      </author>
      <author>
        <name>Nelson, Jennifer</name>
      </author>
      <author>
        <name>Villanueva, Pricilla</name>
      </author>
      <author>
        <name>McGaugh, Garrett</name>
      </author>
      <author>
        <name>Zaslavsky, Ilya</name>
      </author>
      <author>
        <name>Tukey, Robert H</name>
      </author>
      <author>
        <name>Stadnick, Nicole A</name>
        <uri>https://orcid.org/0000-0001-6520-2920</uri>
      </author>
      <author>
        <name>Rabin, Borsika A</name>
      </author>
      <author>
        <name>Laurent, Louise C</name>
      </author>
      <author>
        <name>Seifert, Marva</name>
        <uri>https://orcid.org/0000-0002-7554-6396</uri>
      </author>
    </item>
    <item>
      <title>Aspirin resistance in pregnancy is associated with reduced interleukin-2 (IL-2) concentrations in maternal serum: Implications for aspirin prophylaxis for preeclampsia</title>
      <link>https://escholarship.org/uc/item/86m4144g</link>
      <description>OBJECTIVES: To evaluate the impact of aspirin resistance on the incidence of preeclampsia and maternal serum biomarker levels in pregnant individuals at high-risk of preeclampsia receiving low dose aspirin (LDA).
STUDY DESIGN: We performed a secondary analysis of a randomized, placebo-controlled trial of LDA (60&amp;nbsp;mg daily) for preeclampsia prevention in high-risk individuals (N&amp;nbsp;=&amp;nbsp;524) on pregnancy outcomes and concentrations of PLGF, IL-2, IL-6, thromboxane B2 (TXB&lt;sub&gt;2&lt;/sub&gt;), sTNF-R1 and sTNF-R2 from maternal serum.
MAIN OUTCOME MEASURES: LDA-resistant individuals were defined as those having a TXB&lt;sub&gt;2&lt;/sub&gt; concentration &amp;gt;10&amp;nbsp;ng/ml or &amp;lt;75&amp;nbsp;% reduction in concentration at 24-28&amp;nbsp;weeks after LDA administration. Comparisons of outcomes were performed using a Fisher's Exact Test. Mean concentrations of maternal serum biomarkers were compared using a Student's t-test. Pearson correlation was calculated for all pairwise biomarkers. Longitudinal...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/86m4144g</guid>
      <pubDate>Mon, 16 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Hernandez, Fernando</name>
      </author>
      <author>
        <name>Chavez, Hector</name>
      </author>
      <author>
        <name>Goemans, Sophie L</name>
      </author>
      <author>
        <name>Kirakosyan, Yeva</name>
      </author>
      <author>
        <name>Luevano, Carolina Diaz</name>
      </author>
      <author>
        <name>Canfield, Dana</name>
      </author>
      <author>
        <name>Laurent, Louise C</name>
      </author>
      <author>
        <name>Jacobs, Marni</name>
        <uri>https://orcid.org/0000-0001-6649-6692</uri>
      </author>
      <author>
        <name>Woelkers, Doug</name>
      </author>
      <author>
        <name>Tarsa, Maryam</name>
      </author>
      <author>
        <name>Gyamfi-Bannerman, Cynthia</name>
      </author>
      <author>
        <name>Fisch, Kathleen M</name>
        <uri>https://orcid.org/0000-0002-0117-7444</uri>
      </author>
    </item>
    <item>
      <title>An optimized fractionation method reveals insulin-induced membrane surface localization of GLUT1 to increase glycolysis in LβT2 cells</title>
      <link>https://escholarship.org/uc/item/4p06c1gs</link>
      <description>Insulin is an important regulator of whole-body glucose homeostasis. In insulin sensitive tissues such as muscle and adipose, insulin induces the translocation of glucose transporter 4 (GLUT4) to the cell membrane, thereby increasing glucose uptake. However, insulin also signals in tissues that are not generally associated with glucose homeostasis. In the human reproductive endocrine axis, hyperinsulinemia suppresses the secretion of gonadotropins from gonadotrope cells of the anterior pituitary, thereby linking insulin dysregulation to suboptimal reproductive health. In the mouse, gonadotropes express the insulin receptor which has the canonical signaling response of IRS, AKT, and mTOR activation. However, the functional outcomes of insulin action on gonadotropes are unclear. Here, we demonstrate through use of an optimized cell fractionation protocol that insulin stimulation of the LβT2 gonadotropic cell line results in the unexpected translocation of GLUT1 to the plasma membrane....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4p06c1gs</guid>
      <pubDate>Sun, 8 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Molinar-Inglis, Olivia</name>
      </author>
      <author>
        <name>Wiggins, Kiara</name>
      </author>
      <author>
        <name>Varma, Anjali</name>
      </author>
      <author>
        <name>Del Mundo, Zena</name>
      </author>
      <author>
        <name>Adame, Jose M</name>
      </author>
      <author>
        <name>Cozzo, Alyssa</name>
      </author>
      <author>
        <name>Muñoz, Oscar</name>
      </author>
      <author>
        <name>Le, Uyen-Vy</name>
      </author>
      <author>
        <name>Trinh, Davina</name>
      </author>
      <author>
        <name>Garcia, Alexis C</name>
      </author>
      <author>
        <name>Cisneros-Aguirre, Metztli</name>
      </author>
      <author>
        <name>Ramirez, Monica L Gonzalez</name>
      </author>
      <author>
        <name>Keyes, Jeremiah</name>
      </author>
      <author>
        <name>Zhang, Jin</name>
      </author>
      <author>
        <name>Lawson, Mark A</name>
        <uri>https://orcid.org/0000-0003-2303-3086</uri>
      </author>
      <author>
        <name>Trejo, JoAnn</name>
        <uri>https://orcid.org/0000-0003-4405-6228</uri>
      </author>
      <author>
        <name>Nicholas, Dequina A</name>
      </author>
    </item>
    <item>
      <title>Resident microbes shape the vaginal epithelial glycan landscape</title>
      <link>https://escholarship.org/uc/item/62g375wk</link>
      <description>Epithelial cells are covered in carbohydrates (glycans). This glycan coat or "glycocalyx" interfaces directly with microbes, providing a protective barrier against potential pathogens. Bacterial vaginosis (BV) is a condition associated with adverse health outcomes in which bacteria reside in direct proximity to the vaginal epithelium. Some of these bacteria, including &lt;i&gt;Gardnerella&lt;/i&gt;, produce glycosyl hydrolase enzymes. However, glycans of the human vaginal epithelial surface have not been studied in detail. Here, we elucidate key characteristics of the "normal" vaginal epithelial glycan landscape and analyze the impact of resident microbes on the surface glycocalyx. In human BV, glycocalyx staining was visibly diminished in electron micrographs compared to controls. Biochemical and mass spectrometric analysis showed that, compared to normal vaginal epithelial cells, BV cells were depleted of sialylated &lt;i&gt;N&lt;/i&gt;- and &lt;i&gt;O&lt;/i&gt;-glycans, with underlying galactose residues exposed...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/62g375wk</guid>
      <pubDate>Tue, 3 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Agarwal, Kavita</name>
      </author>
      <author>
        <name>Choudhury, Biswa</name>
      </author>
      <author>
        <name>Robinson, Lloyd S</name>
      </author>
      <author>
        <name>Morrill, Sydney R</name>
      </author>
      <author>
        <name>Bouchibiti, Yasmine</name>
      </author>
      <author>
        <name>Chilin-Fuentes, Daisy</name>
      </author>
      <author>
        <name>Rosenthal, Sara B</name>
      </author>
      <author>
        <name>Fisch, Kathleen M</name>
        <uri>https://orcid.org/0000-0002-0117-7444</uri>
      </author>
      <author>
        <name>Peipert, Jeffrey F</name>
      </author>
      <author>
        <name>Lebrilla, Carlito B</name>
        <uri>https://orcid.org/0000-0001-7190-5323</uri>
      </author>
      <author>
        <name>Allsworth, Jenifer E</name>
      </author>
      <author>
        <name>Lewis, Amanda L</name>
      </author>
      <author>
        <name>Lewis, Warren G</name>
      </author>
    </item>
    <item>
      <title>ReIGNITE Radiation Therapy Boost: A Prospective, International Study of Radiation Oncologists’ Accuracy in Contouring Prostate Tumors for Focal Radiation Therapy Boost on Conventional Magnetic Resonance Imaging Alone or With Assistance of Restriction Spectrum Imaging</title>
      <link>https://escholarship.org/uc/item/5gt5z58q</link>
      <description>PURPOSE: In a phase III randomized trial, adding a radiation boost to tumor(s) visible on MRI improved prostate cancer (PCa) disease-free and metastasis-free survival without additional toxicity. Radiation oncologists' ability to identify prostate tumors is critical to widely adopting intraprostatic tumor radiotherapy boost for patients. A diffusion MRI biomarker, called the Restriction Spectrum Imaging restriction score (RSIrs), has been shown to improve radiologists' identification of clinically significant PCa. We hypothesized that (1) radiation oncologists would find accurately delineating PCa tumors on conventional MRI challenging and (2) using RSIrs maps would improve radiation oncologists' accuracy for PCa tumor delineation.
METHODS AND MATERIALS: In this multi-institutional, international, prospective study, 44 radiation oncologists (participants) and 2 expert radiologists (experts) contoured prostate tumors on 39 total patient cases using conventional MRI with or without...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5gt5z58q</guid>
      <pubDate>Tue, 3 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Lui, Asona J</name>
        <uri>https://orcid.org/0000-0002-0076-3492</uri>
      </author>
      <author>
        <name>Kallis, Karoline</name>
      </author>
      <author>
        <name>Zhong, Allison Y</name>
      </author>
      <author>
        <name>Hussain, Troy S</name>
      </author>
      <author>
        <name>Conlin, Christopher</name>
        <uri>https://orcid.org/0000-0003-4509-8702</uri>
      </author>
      <author>
        <name>Digma, Leonardino A</name>
      </author>
      <author>
        <name>Phan, Nikki</name>
      </author>
      <author>
        <name>Mathews, Ian T</name>
      </author>
      <author>
        <name>Do, Deondre D</name>
      </author>
      <author>
        <name>Domingo, Mariluz Rojo</name>
      </author>
      <author>
        <name>Karunamuni, Roshan</name>
      </author>
      <author>
        <name>Kuperman, Joshua</name>
      </author>
      <author>
        <name>Dale, Anders M</name>
      </author>
      <author>
        <name>Shabaik, Ahmed</name>
      </author>
      <author>
        <name>Rakow-Penner, Rebecca</name>
        <uri>https://orcid.org/0000-0002-2566-1978</uri>
      </author>
      <author>
        <name>Hahn, Michael E</name>
      </author>
      <author>
        <name>Seibert, Tyler M</name>
        <uri>https://orcid.org/0000-0002-4089-7399</uri>
      </author>
    </item>
    <item>
      <title>Development, Usability Testing, and Implementation Assessment of Cancer Related Infertility Score Predictor, an Online Cancer Related Infertility Risk Counseling Tool</title>
      <link>https://escholarship.org/uc/item/3cs6f5t3</link>
      <description>&lt;b&gt;&lt;i&gt;Purpose:&lt;/i&gt;&lt;/b&gt; Oncofertility counseling of female cancer patients lacks efficient access to tailored and valid infertility risk estimates to support shared decision-making on fertility preservation treatments. The objective was to develop, conduct user-centered design, and plan clinic-based implementation of the Cancer Related Infertility Score Predictor (CRISP), a web-based tool to support infertility risk counseling. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; Using a mixed methods design, literature review was undertaken to abstract data on infertility, primary ovarian insufficiency, and amenorrhea risks of common cancer treatments. The CRISP website was programmed to take user input about patient ages and cancer treatments and generate a risk summary. Using user experience methodology and semistructured interviews, usability testing and implementation assessment were conducted with 12 providers recruited from 5 medical centers in Southern California. &lt;b&gt;&lt;i&gt;Results:&lt;/i&gt;&lt;/b&gt; The web-based...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3cs6f5t3</guid>
      <pubDate>Tue, 3 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Nerb, Laura</name>
      </author>
      <author>
        <name>Yang, Emily</name>
        <uri>https://orcid.org/0000-0001-7206-6058</uri>
      </author>
      <author>
        <name>Exume, Dominique</name>
      </author>
      <author>
        <name>Dornisch, Anna</name>
      </author>
      <author>
        <name>Zhou, Beth</name>
      </author>
      <author>
        <name>Helsten, Teresa</name>
      </author>
      <author>
        <name>Kaiser, Bonnie N</name>
      </author>
      <author>
        <name>Romero, Sally AD</name>
        <uri>https://orcid.org/0000-0001-6028-4111</uri>
      </author>
      <author>
        <name>Su, H Irene</name>
      </author>
    </item>
    <item>
      <title>Uterine fibroids with heavy menstrual bleeding stratified by race in a commercial and Medicaid database</title>
      <link>https://escholarship.org/uc/item/5m57731s</link>
      <description>Background: Historically, the clinical characteristics and treatment pathways for patients with uterine fibroids and heavy menstrual bleeding have differed between White and Black women.
Objective: To provide a contemporary comparison of patient characteristics and treatment patterns among White and Black women with uterine fibroids and heavy menstrual bleeding in the United States.
Study Design: This retrospective cohort study included administrative claims data from 46,139 White and 17,297 Black women with uterine fibroids and heavy menstrual bleeding from the Optum Clinformatics database (January 2011-December 2020) and 7353 White and 16,776 Black women from the IBM MarketScan Multi-State Medicaid Insurance database (January 2010-December 2019). Patients were indexed at their initial uterine fibroid diagnosis claim and were required to have a claim for heavy menstrual bleeding and ≥12 months of continuous enrollment pre- and postindex. Patients were followed until the earliest...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5m57731s</guid>
      <pubDate>Sat, 23 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Agarwal, Sanjay K</name>
      </author>
      <author>
        <name>Stokes, Michael</name>
      </author>
      <author>
        <name>Chen, Rong</name>
      </author>
      <author>
        <name>Lickert, Cassandra</name>
      </author>
    </item>
    <item>
      <title>Predictors of treatment failure in young patients undergoing in vitro fertilization</title>
      <link>https://escholarship.org/uc/item/7wk7b99g</link>
      <description>PurposeThe purpose of the study was to evaluate whether routinely collected clinical factors can predict in vitro fertilization (IVF) failure among young, “good prognosis” patients predominantly with secondary infertility who are less than 35&amp;nbsp;years of age.MethodsUsing de-identified clinic records, 414 women &amp;lt;35&amp;nbsp;years undergoing their first autologous IVF cycle were identified. Logistic regression was used to identify patient-driven clinical factors routinely collected during fertility treatment that could be used to model predicted probability of cycle failure.ResultsOne hundred ninety-seven patients with both primary and secondary infertility had a failed IVF cycle, and 217 with secondary infertility had a successful live birth. None of the women with primary infertility had a successful live birth. The significant predictors for IVF cycle failure among young patients were fewer previous live births, history of biochemical pregnancies or spontaneous abortions, lower...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7wk7b99g</guid>
      <pubDate>Fri, 22 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Jacobs, Marni B</name>
        <uri>https://orcid.org/0000-0001-6649-6692</uri>
      </author>
      <author>
        <name>Klonoff-Cohen, Hillary</name>
      </author>
      <author>
        <name>Agarwal, Sanjay</name>
      </author>
      <author>
        <name>Kritz-Silverstein, Donna</name>
      </author>
      <author>
        <name>Lindsay, Suzanne</name>
      </author>
      <author>
        <name>Garzo, V Gabriel</name>
      </author>
    </item>
    <item>
      <title>Impact of Elagolix on Workplace and Household Productivity Among Women with Moderate to Severe Pain Associated with Endometriosis: A Pooled Analysis of Two Phase III Trials</title>
      <link>https://escholarship.org/uc/item/7pw4s54f</link>
      <description>BackgroundEndometriosis profoundly impairs women’s workplace and household productivity.ObjectiveThe aim of this study was to evaluate the impact of elagolix on endometriosis-related workplace and household productivity losses.MethodsData were pooled from two phase III trials of women aged 18–49&amp;nbsp;years with moderate to severe endometriosis-associated pain treated for 6&amp;nbsp;months with elagolix 150&amp;nbsp;mg daily (QD), 200&amp;nbsp;mg twice daily (BID), or placebo. The Health-Related Productivity Questionnaire was administered at baseline, Month 3, and Month 6 to determine workplace and household absenteeism and presenteeism. Productivity changes from baseline were compared between placebo and elagolix doses via analysis of covariance.ResultsWorkplace analyses included 1270 employed women and household analyses included 1565 women. At baseline, women reported average weekly losses of 16 workplace hours, 8.3 household work hours, 45% of scheduled work, and 64% of planned household...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7pw4s54f</guid>
      <pubDate>Fri, 22 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Surrey, Eric S</name>
      </author>
      <author>
        <name>Soliman, Ahmed M</name>
      </author>
      <author>
        <name>Palac, Hannah L</name>
      </author>
      <author>
        <name>Agarwal, Sanjay K</name>
      </author>
    </item>
    <item>
      <title>Elagolix in the treatment of endometriosis: impact beyond pain symptoms</title>
      <link>https://escholarship.org/uc/item/6772c208</link>
      <description>While the most common symptom associated with endometriosis is pelvic pain, the systemic manifestations of the disease and the accompanying adverse psychological, emotional, social, familial, sexual, educational and workplace effects are increasingly recognized. Elagolix is an oral gonadotropin-releasing hormone receptor antagonist that is approved for the management of moderate to severe pain associated with endometriosis. However, the benefits of elagolix extend beyond reducing pain symptoms. This article reviews the non-pain systemic manifestations associated with endometriosis and summarizes the beneficial effects of elagolix on non-pain outcomes. This includes improvements in quality of life, reductions in fatigue and improvements in workplace and household productivity. These results indicate that elagolix provides non-pain benefits in women with endometriosis and improves outcomes that are clinically meaningful to patients.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6772c208</guid>
      <pubDate>Fri, 22 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Archer, David F</name>
      </author>
      <author>
        <name>Soliman, Ahmed M</name>
      </author>
      <author>
        <name>Agarwal, Sanjay K</name>
      </author>
      <author>
        <name>Taylor, Hugh S</name>
      </author>
    </item>
    <item>
      <title>Endometrial microbiota is more diverse in people with endometriosis than symptomatic controls</title>
      <link>https://escholarship.org/uc/item/4t40x33w</link>
      <description>Endometriosis is a chronic, estrogen-dependent gynecological condition affecting approximately 10% of reproductive age women. The most widely accepted theory of its etiology includes retrograde menstruation. Recent reports suggest the uterus is not sterile. Thus, the refluxed menstrual effluent may carry bacteria, and contribute to inflammation, the establishment and growth of endometriotic lesions. Here, we compared and contrasted uterine bacteria (endometrial microbiota) in people with surgically confirmed presence (N = 12) or absence of endometriosis (N = 9) using next-generation 16S rRNA gene sequencing. We obtained an average of &amp;gt; 9000 sequence reads per endometrial biopsy, and found the endometrial microbiota of people with endometriosis was more diverse (greater Shannon Diversity Index and proportion of ‘Other’ taxa) than symptomatic controls (with pelvic pain, surgically confirmed absence of endometriosis; diagnosed with other benign gynecological conditions). The relative...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4t40x33w</guid>
      <pubDate>Fri, 22 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Wessels, Jocelyn M</name>
      </author>
      <author>
        <name>Domínguez, Miguel A</name>
      </author>
      <author>
        <name>Leyland, Nicholas A</name>
      </author>
      <author>
        <name>Agarwal, Sanjay K</name>
      </author>
      <author>
        <name>Foster, Warren G</name>
      </author>
    </item>
    <item>
      <title>Health Care Utilization and Costs Associated with Endometriosis Among Women with Medicaid Insurance.</title>
      <link>https://escholarship.org/uc/item/4861051v</link>
      <description>BACKGROUND: Endometriosis is a painful chronic inflammatory disease caused by endometrial tissue implanting and growing outside the uterus, resulting in pelvic pain symptoms and subfertility. Treatment imposes a substantial economic burden on the patient and health care system.
OBJECTIVE: To evaluate direct health care utilization and costs among women newly diagnosed with endometriosis compared with age-matched controls in a U.S. Medicaid population.
METHODS: This retrospective cohort study used deidentified health care claims from the 2007-2015 MarketScan Multi-State Medicaid Database. Women (aged 18-49 years) newly diagnosed with endometriosis (ICD-9-CM 617.xx) during January 2008 through September 2014 were identified (date of first diagnosis = index date). Age-matched women without endometriosis (controls) were selected from the database and assigned index dates matching the distribution for endometriosis patients. Direct health care resource utilization (HCRU) and costs...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4861051v</guid>
      <pubDate>Fri, 22 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Soliman, Ahmed M</name>
      </author>
      <author>
        <name>Surrey, Eric S</name>
      </author>
      <author>
        <name>Bonafede, Machaon</name>
      </author>
      <author>
        <name>Nelson, James K</name>
      </author>
      <author>
        <name>Vora, Jamie B</name>
      </author>
      <author>
        <name>Agarwal, Sanjay K</name>
      </author>
    </item>
    <item>
      <title>Rethinking endometriosis care: applying the chronic care model via a multidisciplinary program for the care of women with endometriosis</title>
      <link>https://escholarship.org/uc/item/40v8t6f7</link>
      <description>Endometriosis is a chronic, painful disease without a cure. Due largely to chronic pain, endometriosis can lead to significant physical, mental, relationship, and financial burdens. Within the conventional single provider model of care-in which the patient is primarily taken care of by her physician and complementary strategies based on psychology, nutrition, pain medicine, pelvic physical therapy, and so on may not be readily available in a coordinated manner-most women with endometriosis live with unresolved pain and the consequences of that pain. We therefore propose that there is an urgent need to search for alternative models of care. In the current paper, we discuss our experiences with an model of care in which we adopt a long-term, patient-focused, and multidisciplinary chronic care model for women with endometriosis. Our objective is to improve long-term clinical outcomes for women with endometriosis. For geographical areas and healthcare systems in which it is feasible,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/40v8t6f7</guid>
      <pubDate>Fri, 22 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Agarwal, Sanjay K</name>
      </author>
      <author>
        <name>Foster, Warren G</name>
      </author>
      <author>
        <name>Groessl, Erik J</name>
      </author>
    </item>
    <item>
      <title>A critical appraisal of the circulating levels of differentially expressed microRNA in endometriosis†</title>
      <link>https://escholarship.org/uc/item/4038n9zm</link>
      <description>Endometriosis is a common gynecological condition characterized by estrogen dependence, chronic pelvic pain, infertility, and diagnostic delay of between 5.4 and 12&amp;nbsp;years. Despite extensive study, no biomarker, either alone or in combination with other markers, has proven superior to laparoscopy for the diagnosis of endometriosis. Recent studies report that circulating levels of differentially expressed microRNA (miRNA) in women with endometriosis compared with controls are potential diagnostic tools. However, the lack of replication and absence of validated differential expression in novel study populations have led some to question the diagnostic value of miRNA. To elucidate potential reasons for the lack of replication of study results and explore future directions to enhance replicability of circulating miRNA results, we carried out an electronic search of the miRNA literature published between 2000 and 2020. Eighteen studies were identified in which 63 different miRNAs...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4038n9zm</guid>
      <pubDate>Fri, 22 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Leonova, Anna</name>
      </author>
      <author>
        <name>Turpin, Victoria E</name>
      </author>
      <author>
        <name>Agarwal, Sanjay K</name>
      </author>
      <author>
        <name>Leonardi, Mathew</name>
      </author>
      <author>
        <name>Foster, Warren G</name>
      </author>
    </item>
    <item>
      <title>Factors affecting stability of plasma brain-derived neurotrophic factor</title>
      <link>https://escholarship.org/uc/item/2jg5f9gs</link>
      <description>Circulating concentrations of brain-derived neurotrophic factor (BDNF) have been linked to cancer, neuropsychiatric, diabetes, and gynecological disorders. However, factors influencing plasma storage and subsequent BDNF quantification are incompletely understood. Therefore, the anticoagulant used in plasma separator tubes, storage-time, storage-temperature, and repeated freeze–thaw cycles on circulating BDNF concentrations was evaluated. Peripheral blood samples were collected from healthy women (n = 14) and men (n = 10) recruited prospectively from McMaster University (August 2014). Blood was collected from the cubital vein into plasma separator tubes containing five different anticoagulant systems [K2EDTA, Li-Hep, Li-Hep (gel), Na-Hep, Na-Hep (glass)], and placed on ice for transport to the lab for centrifugation. Plasma samples (n = 16) collected in K2EDTA tubes from women recruited to a previous study (April 2011 to December 2012) were used to determine the effect of multiple...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2jg5f9gs</guid>
      <pubDate>Fri, 22 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Wessels, Jocelyn M</name>
      </author>
      <author>
        <name>Agarwal, Ravi K</name>
      </author>
      <author>
        <name>Somani, Aamer</name>
      </author>
      <author>
        <name>Verschoor, Chris P</name>
      </author>
      <author>
        <name>Agarwal, Sanjay K</name>
      </author>
      <author>
        <name>Foster, Warren G</name>
      </author>
    </item>
    <item>
      <title>Describing the Patient Journey of Women with Claims for Uterine Fibroids and Heavy Menstrual Bleeding Using a Commercial Database (2011–2020)</title>
      <link>https://escholarship.org/uc/item/2gz5w0g3</link>
      <description>Introduction: This retrospective database claims analysis describes the clinical characteristics and treatment patterns of commercially insured United States women with uterine fibroids (UF) and heavy menstrual bleeding (HMB).
Methods: Women age 18-55 years with an incident UF diagnosis (index date) between 1/1/2012 and 12/31/2019 and ≥1 claim for HMB (UF-HMB), were identified from the Optum&lt;sup&gt;®&lt;/sup&gt; Clinformatics&lt;sup&gt;®&lt;/sup&gt; database. Outcomes included clinical characteristics, pharmacologic therapy use, and surgeries/procedures. Regression models were used to identify factors associated with time to post-diagnosis hormonal therapy and hysterectomy.
Results: A total of 85,428 women had UF-HMB (mean [SD] age, 43.7 [6.4] years). The median follow-up was 3.2 years. After HMB, the most common symptoms were pelvic pressure/pain (27.6%) and backache (17.5%). Within 6 months of UF diagnosis, 40.2% of patients had received only pharmacologic therapy; 25.5% had received no treatment;...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2gz5w0g3</guid>
      <pubDate>Fri, 22 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Agarwal, Sanjay K</name>
      </author>
      <author>
        <name>Stokes, Michael</name>
      </author>
      <author>
        <name>Kung, Tiffany</name>
      </author>
      <author>
        <name>Tilney, Rong</name>
      </author>
      <author>
        <name>Lickert, Cassandra</name>
      </author>
    </item>
    <item>
      <title>Endometriosis Symptoms and Their Impacts on the Daily Lives of US Women: Results from an Interview Study</title>
      <link>https://escholarship.org/uc/item/1tc745sw</link>
      <description>Objective: This interview study sought to capture patients' experiences and perceptions of endometriosis symptoms and their impacts on daily life, as described by women in their own words. Using open-ended questions and a concept-elicitation approach, this study assessed the signs and symptoms of endometriosis and their impacts on different aspects of quality of life, including daily activities, functioning, and well-being.
Materials and Methods: This interview study included US women with moderate-to-severe endometriosis-associated pain who completed one of two Phase 3, randomized, double-blind, placebo-controlled trials (SPIRIT 1 or SPIRIT 2; ClinicalTrials.gov identifiers: NCT03204318, NCT03204331). Interviews were conducted via a web/Internet-based video platform or telephone by trained interviewers, using open-ended questions in a concept-elicitation approach, and probes as needed to obtain additional feedback on the burden of endometriosis. Qualitative data from the interviews...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1tc745sw</guid>
      <pubDate>Fri, 22 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Hunsche, Elke</name>
      </author>
      <author>
        <name>Gauthier, Martha</name>
      </author>
      <author>
        <name>Witherspoon, Brooke</name>
      </author>
      <author>
        <name>Rakov, Viatcheslav</name>
      </author>
      <author>
        <name>Agarwal, Sanjay K</name>
      </author>
    </item>
    <item>
      <title>Cancer-Immunity Marker RNA Expression Levels across Gynecologic Cancers: Implications for Immunotherapy</title>
      <link>https://escholarship.org/uc/item/2pb875w5</link>
      <description>Our objective was to characterize cancer-immunity marker expression in gynecologic cancers and compare immune landscapes between gynecologic tumor subtypes and with nongynecologic solid tumors. RNA expression levels of 51 cancer-immunity markers were analyzed in patients with gynecologic cancers versus nongynecologic cancers, and normalized to a reference population of 735 control cancers, ranked from 0 to 100, and categorized as low (0-24), moderate (25-74), or high (75-100) percentile rank. Of the 72 patients studied, 43 (60%) had ovarian, 24 (33%) uterine, and 5 (7%) cervical cancer. No two immune profiles were identical according to expression rank (0-100) or rank level (low, moderate, or high). Patients with cervical cancer had significantly higher expression level ranks of immune activating, proinflammatory, tumor-infiltrating lymphocyte markers, and checkpoints than patients with uterine or ovarian cancer (P &amp;lt; 0.001 for all comparisons). However, there were no significant...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2pb875w5</guid>
      <pubDate>Tue, 19 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Jou, Jessica</name>
      </author>
      <author>
        <name>Kato, Shumei</name>
      </author>
      <author>
        <name>Miyashita, Hirotaka</name>
      </author>
      <author>
        <name>Thangathurai, Kartheeswaran</name>
      </author>
      <author>
        <name>Pabla, Sarabjot</name>
      </author>
      <author>
        <name>DePietro, Paul</name>
      </author>
      <author>
        <name>Nesline, Mary K</name>
      </author>
      <author>
        <name>Conroy, Jeffrey M</name>
      </author>
      <author>
        <name>Rubin, Eitan</name>
      </author>
      <author>
        <name>Eskander, Ramez N</name>
      </author>
      <author>
        <name>Kurzrock, Razelle</name>
      </author>
    </item>
    <item>
      <title>Variation in surgical treatment by body mass index in patients with invasive lobular carcinoma of the breast</title>
      <link>https://escholarship.org/uc/item/6mg066xb</link>
      <description>PurposePatients with invasive lobular carcinoma (ILC) face high rates of positive margins and completion mastectomy, which can be improved with the use of specific techniques, such as oncoplastic surgery. However, prior studies have shown that type of breast cancer surgery performed is also associated with patient factors such as elevated body mass index (BMI). Thus, this study investigates whether BMI impacts the type of surgical interventions in patients with ILC.MethodsA retrospective analysis of 705 patients with stage I–III ILC from an institutional database was conducted. Patients were stratified by BMI (underweight, normal weight, overweight, obese). Pearson’s Chi-square, ANOVA, and multivariable logistic regression were used to evaluate the relationship between BMI and surgical procedures.ResultsBreast-conserving surgery (BCS) was the initial operation in 60% of patients, with no significant difference by BMI. Among those undergoing BCS, patients with obese BMI were significantly...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6mg066xb</guid>
      <pubDate>Wed, 13 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Falade, Israel O</name>
      </author>
      <author>
        <name>Switalla, Kayla M</name>
      </author>
      <author>
        <name>Baxter, Molly E</name>
      </author>
      <author>
        <name>Quirarte, Astrid</name>
      </author>
      <author>
        <name>Record, Helena</name>
      </author>
      <author>
        <name>Rothschild, Harriet T</name>
      </author>
      <author>
        <name>Clelland, Elle N</name>
      </author>
      <author>
        <name>Mukhtar, Rita A</name>
        <uri>https://orcid.org/0000-0001-8079-7846</uri>
      </author>
    </item>
    <item>
      <title>Pilot Study of IL-1 Antagonist Anakinra for Treatment of Endometriosis</title>
      <link>https://escholarship.org/uc/item/5xg8w2d2</link>
      <description>Purpose: To evaluate the impact of an interleukin-1 (IL-1) antagonist anakinra (Kineret&lt;sup&gt;®&lt;/sup&gt;) on endometriosis-related quality of life (QoL), pain, and inflammatory biomarkers.
Methods: This was a single-site, randomized, double-blinded, placebo-controlled, cross-over pilot clinical study of patients recruited at an academic specialty clinic. Eligible participants were females aged 18-45 years with menstrual cycles every 24-32 days. Subjects had moderate to severe dysmenorrhea and either a surgical diagnosis of endometriosis or an endometrioma on imaging. Subjects were randomly assigned in a double-blind fashion to receive either the study drug or placebo administered as daily injections during the first 3 periods and then the alternate intervention for the next 3 periods.
Results: Fifteen subjects completed the 6 menstrual cycle study. After each period, they completed the Endometriosis Health Profile-30 (EHP-30) QoL questionnaire and an assessment of dysmenorrhea using...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5xg8w2d2</guid>
      <pubDate>Wed, 13 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Sullender, Renee T</name>
      </author>
      <author>
        <name>Agarwal, Ravi K</name>
      </author>
      <author>
        <name>Jacobs, Marni B</name>
        <uri>https://orcid.org/0000-0001-6649-6692</uri>
      </author>
      <author>
        <name>Wessels, Jocelyn M</name>
      </author>
      <author>
        <name>Foster, Warren G</name>
      </author>
      <author>
        <name>Agarwal, Sanjay K</name>
      </author>
    </item>
    <item>
      <title>Placental lesions in systemic lupus erythematosus pregnancies associated with small for gestational age infants</title>
      <link>https://escholarship.org/uc/item/8n61c4jm</link>
      <description>OBJECTIVES: Up to a quarter of pregnant individuals with SLE have small for gestational age (SGA) infants. We aimed to characterize placental pathology associated with SGA infants in SLE.
METHODS: We retrospectively analysed SLE deliveries with placental analysis at UCSD from November 2018 to October 2023, comparing SLE pregnancies resulting in SGA to those that did not, and additionally, to matched pregnancies with SGA but without SLE.
RESULTS: Placental analysis was available only for 28/70 (40%) SLE deliveries, which had high rates of adverse outcomes (75%). All exhibited at least one histopathologic abnormality. Key findings distinguishing 12 SLE placentas resulting in SGA infants (vs.16 without) included small placental disc for gestational age (100% vs 56%, P = 0.01), placental disc infarct (50% vs 6%, P = 0.02) and increased perivillous fibrin deposition (PVFD, 58% vs 0%, P = 0.001). All seven SLE placentas with increased PVFD resulted in SGA infants. Compared with matched...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8n61c4jm</guid>
      <pubDate>Sat, 9 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Dhital, Rashmi</name>
      </author>
      <author>
        <name>Jacobs, Marni</name>
        <uri>https://orcid.org/0000-0001-6649-6692</uri>
      </author>
      <author>
        <name>Smith, Chelsey JF</name>
      </author>
      <author>
        <name>Parast, Mana M</name>
      </author>
    </item>
    <item>
      <title>Recent Therapeutic Advances in Gynecologic Oncology: A Review</title>
      <link>https://escholarship.org/uc/item/9g104988</link>
      <description>Gynecologic malignancies have high incidence rates both nationally and internationally, and cervical, endometrial, and ovarian cancers account for high mortality rates worldwide. Significant research is ongoing to develop targeted therapies to address unmet needs in the field and improve patient outcomes. As tumors mutate and progress through traditional lines of treatment, new therapies must be developed to overcome resistance and target cancer-specific receptors and mutations. Recent advances in the development of immunotherapy and antibody-drug conjugates have resulted in compelling and clinically meaningful results in cervical, endometrial, and ovarian cancers. In the last decade, several immunotherapy agents have received FDA approval or NCCN guideline recommendation for the treatment of gynecologic malignancies, including dostarlimab for advanced or recurrent endometrial cancer and pembrolizumab for advanced or recurrent cervical and endometrial cancers. Several other immunotherapeutic...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9g104988</guid>
      <pubDate>Fri, 8 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Wilson, Elise M</name>
      </author>
      <author>
        <name>Eskander, Ramez N</name>
      </author>
      <author>
        <name>Binder, Pratibha S</name>
      </author>
    </item>
    <item>
      <title>Pregnancy-associated large pelvic desmoid tumor: A case report of fetal-protective strategies and fertility preservation</title>
      <link>https://escholarship.org/uc/item/11r2k388</link>
      <description>•Desmoid fibromatoses grow rapidly during the high estrogen-state of pregnancy.•Mass effect on the bladder is a complication of abdominal desmoid fibromatoses.•Cryoablation, doxorubicin, and post-partum prolactin are fetal-protective treatments.•Desmoid tumors can be effectively treated with fetal-protective strategies.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/11r2k388</guid>
      <pubDate>Fri, 8 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Marsh-Armstrong, Brennan</name>
      </author>
      <author>
        <name>Veerapong, Jula</name>
      </author>
      <author>
        <name>Taddonio, Michael</name>
      </author>
      <author>
        <name>Boles, Sarah</name>
      </author>
      <author>
        <name>Sicklick, Jason K</name>
      </author>
      <author>
        <name>Binder, Pratibha</name>
      </author>
    </item>
    <item>
      <title>Children with single ventricle heart disease have a greater increase in sRAGE after cardiopulmonary bypass</title>
      <link>https://escholarship.org/uc/item/9z56n16x</link>
      <description>INTRODUCTION: Reducing cardiopulmonary bypass (CPB) induced inflammatory injury is a potentially important strategy for children undergoing multiple operations for single ventricle palliation. We sought to characterize the soluble receptor for advanced glycation end products (sRAGE), a protein involved in acute lung injury and inflammation, in pediatric patients with congenital heart disease and hypothesized that patients undergoing single ventricle palliation would have higher levels of sRAGE following bypass than those with biventricular physiologies.
METHODS: This was a prospective, observational study of children undergoing CPB. Plasma samples were obtained before and after bypass. sRAGE levels were measured and compared between those with biventricular and single ventricle heart disease using descriptive statistics and multivariate analysis for risk factors for lung injury.
RESULTS: sRAGE levels were measured in 40 patients: 19 with biventricular and 21 with single ventricle...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9z56n16x</guid>
      <pubDate>Tue, 5 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Brooks, Bonnie A</name>
      </author>
      <author>
        <name>Sinha, Pranava</name>
      </author>
      <author>
        <name>Staffa, Steven J</name>
      </author>
      <author>
        <name>Jacobs, Marni B</name>
        <uri>https://orcid.org/0000-0001-6649-6692</uri>
      </author>
      <author>
        <name>Freishtat, Robert J</name>
      </author>
      <author>
        <name>Patregnani, Jason T</name>
      </author>
    </item>
    <item>
      <title>Early screening for gestational diabetes mellitus: a meta-analysis of randomized controlled trials</title>
      <link>https://escholarship.org/uc/item/4fx083x2</link>
      <description>OBJECTIVE: Current evidence is conflicting on whether early screening and treatment for gestational diabetes mellitus improve pregnancy outcomes. Thus, this systematic review and meta-analysis of randomized controlled trials aimed to assess the rate of adverse pregnancy outcomes among participants with early screening and treatment for gestational diabetes mellitus vs those with routine care.
DATA SOURCES: A systematic review of the literature was conducted using MEDLINE, Scopus, ClinicalTrials.gov, EMBASE, ScienceDirect, the Cochrane Library at the Central Register of Controlled Trials, and SciELO from inception to November 2021.
STUDY ELIGIBILITY CRITERIA: Studies were eligible for inclusion if they described randomized controlled trials comparing early screening with routine care for gestational diabetes mellitus to assess the effects of early screening and treatment on pregnancy outcomes.
METHODS: All randomized controlled trials comparing early vs standard screening of gestational...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4fx083x2</guid>
      <pubDate>Tue, 5 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>McLaren, Rodney A</name>
      </author>
      <author>
        <name>Ruymann, Kathryn R</name>
      </author>
      <author>
        <name>Ramos, Gladys A</name>
      </author>
      <author>
        <name>Osmundson, Sarah S</name>
      </author>
      <author>
        <name>Jauk, Victoria</name>
      </author>
      <author>
        <name>Berghella, Vincenzo</name>
      </author>
    </item>
    <item>
      <title>Advancing stem cell technologies for conservation of wildlife biodiversity</title>
      <link>https://escholarship.org/uc/item/90x6q751</link>
      <description>Wildlife biodiversity is essential for healthy, resilient and sustainable ecosystems. For biologists, this diversity also represents a treasure trove of genetic, molecular and developmental mechanisms that deepen our understanding of the origins and rules of life. However, the rapid decline in biodiversity reported recently foreshadows a potentially catastrophic collapse of many important ecosystems and the associated irreversible loss of many forms of life on our planet. Immediate action by conservationists of all stripes is required to avert this disaster. In this Spotlight, we draw together insights and proposals discussed at a recent workshop hosted by Revive &amp;amp; Restore, which gathered experts to discuss how stem cell technologies can support traditional conservation techniques and help protect animal biodiversity. We discuss reprogramming, in vitro gametogenesis, disease modelling and embryo modelling, and we highlight the prospects for leveraging stem cell technologies...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/90x6q751</guid>
      <pubDate>Thu, 10 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Hutchinson, Ashlee M</name>
      </author>
      <author>
        <name>Appeltant, Ruth</name>
      </author>
      <author>
        <name>Burdon, Tom</name>
      </author>
      <author>
        <name>Bao, Qiuye</name>
      </author>
      <author>
        <name>Bargaje, Rhishikesh</name>
      </author>
      <author>
        <name>Bodnar, Andrea</name>
      </author>
      <author>
        <name>Chambers, Stuart</name>
      </author>
      <author>
        <name>Comizzoli, Pierre</name>
      </author>
      <author>
        <name>Cook, Laura</name>
        <uri>https://orcid.org/0000-0002-4459-2592</uri>
      </author>
      <author>
        <name>Endo, Yoshinori</name>
      </author>
      <author>
        <name>Harman, Bob</name>
      </author>
      <author>
        <name>Hayashi, Katsuhiko</name>
      </author>
      <author>
        <name>Hildebrandt, Thomas</name>
      </author>
      <author>
        <name>Korody, Marisa L</name>
      </author>
      <author>
        <name>Lakshmipathy, Uma</name>
      </author>
      <author>
        <name>Loring, Jeanne F</name>
      </author>
      <author>
        <name>Munger, Clara</name>
      </author>
      <author>
        <name>Ng, Alex HM</name>
      </author>
      <author>
        <name>Novak, Ben</name>
      </author>
      <author>
        <name>Onuma, Manabu</name>
      </author>
      <author>
        <name>Ord, Sara</name>
      </author>
      <author>
        <name>Paris, Monique</name>
      </author>
      <author>
        <name>Pask, Andrew J</name>
      </author>
      <author>
        <name>Pelegri, Francisco</name>
      </author>
      <author>
        <name>Pera, Martin</name>
      </author>
      <author>
        <name>Phelan, Ryan</name>
      </author>
      <author>
        <name>Rosental, Benyamin</name>
      </author>
      <author>
        <name>Ryder, Oliver A</name>
      </author>
      <author>
        <name>Sukparangsi, Woranop</name>
      </author>
      <author>
        <name>Sullivan, Gareth</name>
      </author>
      <author>
        <name>Tay, Nicole Liling</name>
      </author>
      <author>
        <name>Traylor-Knowles, Nikki</name>
      </author>
      <author>
        <name>Walker, Shawn</name>
      </author>
      <author>
        <name>Weberling, Antonia</name>
      </author>
      <author>
        <name>Whitworth, Deanne J</name>
      </author>
      <author>
        <name>Williams, Suzannah A</name>
      </author>
      <author>
        <name>Wojtusik, Jessye</name>
      </author>
      <author>
        <name>Wu, Jun</name>
      </author>
      <author>
        <name>Ying, Qi-Long</name>
      </author>
      <author>
        <name>Zwaka, Thomas P</name>
      </author>
      <author>
        <name>Kohler, Timo N</name>
      </author>
    </item>
    <item>
      <title>RNA editing regulates host immune response and T cell homeostasis in SARS-CoV-2 infection</title>
      <link>https://escholarship.org/uc/item/3nb364jm</link>
      <description>Adenosine to inosine (A-to-I) RNA editing by ADAR1 has been implicated in maintaining self-tolerance, preventing autoimmunity, and mediating antiviral immunity. Foreign viral double-stranded RNA triggers rapid interferon response and activates ADAR1 in the host immune system. Emerging data points to a role of ADAR1 A-to-I editing in the inflammatory response associated with severe COVID-19 disease. We identify A-to-I editing events within human whole transcriptome data from SARS-CoV-2 infected individuals, non-infected individuals, and individuals with other viral illnesses from nasopharyngeal swabs. High levels of RNA editing in host cells are associated with low SARS-CoV-2 viral load (p = 9.27 E-06), suggesting an inhibitory effect of ADAR1 on viral infection. Additionally, we find differentially expressed genes associated with RNA-modifications and interferon response. Single cell RNA-sequencing analysis of SARS-CoV-2 infected nasopharyngeal swabs reveals that cytotoxic CD8...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3nb364jm</guid>
      <pubDate>Mon, 16 Sep 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Huang, Molly</name>
      </author>
      <author>
        <name>Mark, Adam</name>
      </author>
      <author>
        <name>Pham, Jessica</name>
      </author>
      <author>
        <name>Vera, Karina</name>
      </author>
      <author>
        <name>Saravia-Butler, Amanda M</name>
      </author>
      <author>
        <name>Beheshti, Afshin</name>
      </author>
      <author>
        <name>Jiang, Qingfei</name>
      </author>
      <author>
        <name>Fisch, Kathleen M</name>
        <uri>https://orcid.org/0000-0002-0117-7444</uri>
      </author>
    </item>
  </channel>
</rss>
